Processing 00000000.tx.1: Parkin genetics: one model for Parkinson's disease Ignacio F. 

Phrase: "Parkin genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: ":"

Phrase: "one model for Parkinson's disease Ignacio F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0683033:disease model [Intellectual Product]
   774   C0684309:Disease model [Experimental Model of Disease]
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.2: Mata, Paul J. 

Phrase: "Mata,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0327149:mata [Reptile]

Phrase: "Paul J."
Processing 00000000.tx.3: Lockhart and Matthew J. 

Phrase: "Lockhart"

Phrase: "and"

Phrase: "Matthew J."
Processing 00000000.tx.4: Farrer* Laboratories of Neurogenetics, Department of Neuroscience, Mayo Clinic Jacksonville, FL, USA Received January 12, 2004; 

Phrase: "Farrer"

Phrase: "* Laboratories of Neurogenetics,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0022877:Laboratories [Manufactured Object,Organization]
   790   C1619828:Laboratories [Intellectual Product]
   756 E C3244292:laboratory [Functional Concept]

Phrase: "Department of Neuroscience,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "Mayo Clinic Jacksonville,"

Phrase: "FL,"

Phrase: "USA Received January 12,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0041703:USA [Geographic Area]
   812   C1514756:Received [Qualitative Concept]

Phrase: "2004"

Phrase: ";"
Processing 00000000.tx.5: Revised and Accepted February 5, 2004  ABSTRACT TOP ABSTRACT INTRODUCTION PARKIN-PROVEN PD: CLINICAL AND... 

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted February 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2004  ABSTRACT TOP ABSTRACT INTRODUCTION PARKIN-PROVEN PD"

Phrase: ":"

Phrase: "CLINICAL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "AND..."
Processing 00000000.tx.6: PARKIN: MOLECULAR GENETICS PARKIN GENOMIC ORGANIZATION PARKIN, AN E3 UBIQUITIN... 

Phrase: "PARKIN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "MOLECULAR GENETICS PARKIN GENOMIC ORGANIZATION PARKIN,"

Phrase: "AN E3 UBIQUITIN..."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.7: MODELS OF PARKIN FUNCTION CONCLUSIONS REFERENCES  The genetic epidemiology of late-onset idiopathic Parkinson's disease (PD) and parkin-proven parkinsonism (AR-JP) are limited. 

Phrase: "MODELS OF PARKIN FUNCTION CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Models [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The genetic epidemiology of late-onset idiopathic Parkinson's disease"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   764   C0872180:Genetic Epidemiology [Occupation or Discipline]
   762   C0019247:Genetic disease [Disease or Syndrome]
   742   C0014507:Epidemiology [Biomedical Occupation or Discipline]
   742   C0014508:epidemiology [Functional Concept]
   742   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   742   C0314603:Genetic [Functional Concept]
   742   C0699910:epidemiology [Health Care Activity]
   720 E C2316203:Genetic diseases [Finding]
   720 E C2924406:Genetic diseases [Laboratory Procedure]

Phrase: "(PD)"

Phrase: "and"

Phrase: "parkin-proven parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "(AR-JP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: ")"

Phrase: "are"

Phrase: "limited."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.8: The clinical phenotype, prognosis and treatments are similar although PD is prevalent while AR-JP is rare. 

Phrase: "The clinical phenotype,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "prognosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033325:Prognosis [Health Care Activity]

Phrase: "and"

Phrase: "treatments"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0087111:Treatments [Therapeutic or Preventive Procedure]
   966 E C0039798:treatment [Functional Concept]
   966 E C1522326:Treatment [Functional Concept]
   966 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   966 E C1705169:Treatment [Conceptual Entity]
   966 E C3538994:TREATMENT [Research Activity]

Phrase: "are"

Phrase: "similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "although"

Phrase: "PD"

Phrase: "is"

Phrase: "prevalent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0033105:Prevalence [Quantitative Concept]
   928   C0220900:prevalence [Quantitative Concept]

Phrase: "while"

Phrase: "AR-JP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "is"

Phrase: "rare."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521114:Rare [Temporal Concept]
  1000   C0522498:Rare [Qualitative Concept]
  1000   C1514917:RARE [Gene or Genome]
Processing 00000000.tx.9: Molecular genetic and functional analysis suggests the E3 ubiquitin protein ligase activity of parkin, and the ubiquitin-proteosomal pathway, is central to disease pathogenesis. 

Phrase: "Molecular genetic"
Meta Candidates (Total=19; Excluded=15; Pruned=0; Remaining=4)
  1000   C0086345:Molecular Genetic [Biomedical Occupation or Discipline]
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   861   C1521991:Molecular [Qualitative Concept]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   789 E C0567416:Molecule [Substance]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "functional analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0558024:Functional analysis [Health Care Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the E3 ubiquitin protein ligase activity of parkin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1150685:ubiquitin-protein ligase activity [Molecular Function]
           ubiquitin-ligase activity
   770   C1150651:ligase activity [Molecular Function]
   767   C1325411:ubiquitin activity [Molecular Function]
   767   C1537044:protein activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "the ubiquitin-proteosomal pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "is"

Phrase: "central to disease pathogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205099:Central [Spatial Concept]
   770   C1879652:Central - [Laboratory Procedure]
Processing 00000000.tx.10: Herein, we compare and contrast PD and AR-JP and discuss the implications of recent data about parkin's genomic organization, regulation and function.  

Phrase: "Herein,"

Phrase: "we"

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "and"

Phrase: "contrast PD"

Phrase: "and"

Phrase: "AR-JP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "and"

Phrase: "discuss"

Phrase: "the implications of recent data"

Phrase: "about parkin's genomic organization,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0029237:Organisation [Physiologic Function]
   827   C0029246:Organization [Organization]
   827   C0220885:organization [Qualitative Concept]
   827   C1300196:Organization [Functional Concept]
   827   C1522486:Organization [Professional or Occupational Group]

Phrase: "regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.11: INTRODUCTION TOP ABSTRACT INTRODUCTION PARKIN-PROVEN PD: CLINICAL AND... 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION PARKIN-PROVEN PD"

Phrase: ":"

Phrase: "CLINICAL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "AND..."
Processing 00000000.tx.12: PARKIN: MOLECULAR GENETICS PARKIN GENOMIC ORGANIZATION PARKIN, AN E3 UBIQUITIN... 

Phrase: "PARKIN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "MOLECULAR GENETICS PARKIN GENOMIC ORGANIZATION PARKIN,"

Phrase: "AN E3 UBIQUITIN..."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.13: MODELS OF PARKIN FUNCTION CONCLUSIONS REFERENCES  Parkinson's disease (PD) is a prevalent age-associated progressive neurodegenerative disorder characterized by a triad of resting tremor, bradykinesia, rigidity and postural instability. 

Phrase: "MODELS OF PARKIN FUNCTION CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Models [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(PD)"

Phrase: "is"

Phrase: "a prevalent age-associated progressive neurodegenerative disorder"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C1292726:Associated disorder [Functional Concept]
   839   C1864985:Progressive disorder [Finding]
   827   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   799   C0012634:Disorder [Disease or Syndrome]

Phrase: "characterized by a triad of resting tremor,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0234379:Resting Tremor [Sign or Symptom]
   748   C0035253:Resting [Daily or Recreational Activity]
   748   C0040822:Tremor [Sign or Symptom]
   748   C0076994:triad [Biomedical or Dental Material,Organic Chemical]
   748   C1179122:triad [Cell Component]
   748   C1512899:resting [Cell]
   748   C1880022:Characterized [Activity]
   748   C1963252:Tremor [Finding]
   714 E C1622890:ResT [Molecular Function]

Phrase: "bradykinesia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0233565:Bradykinesia [Sign or Symptom]

Phrase: "rigidity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0026837:Rigidity, NOS [Sign or Symptom]
  1000   C0700109:rigidity [Natural Phenomenon or Process]
   928 E C0231517:Rigid [Individual Behavior]
   928 E C1882952:RIGID [Phenomenon or Process]

Phrase: "and"

Phrase: "postural instability."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1843921:Postural instability [Finding]
   861   C1444783:Instability [Finding]
Processing 00000000.tx.14: Patients often display excellent initial symptomatic response to levodopa therapy, however there is no current treatment to slow PD progression (1,2). 

Phrase: "Patients often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "excellent initial symptomatic response to levodopa therapy,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "however there"

Phrase: "is"

Phrase: "no current treatment to slow PD progression"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C2827774:Current Treatment [Therapeutic or Preventive Procedure]
   774   C0746919:NO TREATMENT [Finding]
   774   C3275118:NO TREATMENT [Finding]
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: PD is a complex, multifactorial syndrome of largely unknown etiology that typically manifests after the age of 50 years. 

Phrase: "PD"

Phrase: "is"

Phrase: "a complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "multifactorial syndrome of largely unknown etiology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0039082:Syndrome [Disease or Syndrome]

Phrase: "that typically"

Phrase: "manifests after the age of 50 years."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   774   C1510829:Age-Years [Temporal Concept]
   748   C0001779:Age [Organism Attribute]
   748   C0205319:Manifest [Functional Concept]
   748   C0439234:years [Temporal Concept]
   714 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.16: Common, co-existing features may include depression, dementia and autonomic dysfunction (3). 

Phrase: "Common,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205214:Common [Quantitative Concept]
  1000   C1522138:Common [Functional Concept]
  1000   C3245511:common [Intellectual Product]

Phrase: "co-existing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2987476:Exist [Conceptual Entity]

Phrase: "features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1521970:Feature [Qualitative Concept]
   966   C1706388:Feature [Conceptual Entity]
   966   C2346469:Feature [Qualitative Concept]
   966   C2348519:Feature [Qualitative Concept]

Phrase: "may"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "depression,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0011570:Depression [Mental or Behavioral Dysfunction]
  1000   C0011581:Depression [Mental or Behavioral Dysfunction]
  1000   C0344315:Depression [Finding]
  1000   C0349217:depression nos [Mental or Behavioral Dysfunction]
  1000   C0460137:Depression [Functional Concept]
   928 E C0549249:DEPRESSED [Finding]

Phrase: "dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "autonomic dysfunction"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0741307:Autonomic dysfunction [Pathologic Function]
   861   C0004388:Autonomic [Body System]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.17: Pathologically, the disease is associated with neuronal loss in the substantia nigra and locus ceruleus, with Lewy body inclusions in surviving cells within the brainstem (4). 

Phrase: "Pathologically,"

Phrase: "the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "associated with neuronal loss"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1850496:Neuronal loss [Finding]
   797 E C0598940:neuron loss [Finding]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1517945:Loss [Quantitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "locus ceruleus,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023951:Locus Caeruleus [Body Part, Organ, or Organ Component]
  1000   C1289445:Locus ceruleus [Body Part, Organ, or Organ Component]
   861   C1708726:Locus [Gene or Genome]

Phrase: "with Lewy body inclusions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0007637:body inclusion [Cell Component]
   793   C1512693:Inclusion [Qualitative Concept]
   734   C0085200:Lewy Body [Cell Component]

Phrase: "in surviving cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "within the brainstem"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
  1000   C1306665:Brainstem [Body Part, Organ, or Organ Component]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.18: Definitive diagnosis is post mortem as clinically many other disorders manifest with parkinsonism without Lewy bodies, including drug-induced parkinsonism, post-encephalytic parkinsonism, progressive supranuclear palsy and spinocerebellar ataxia (types 2, 3) (5,6). 

Phrase: "Definitive diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011900:Diagnosis [Finding]
   861   C1704338:diagnosis [Qualitative Concept]
   861   C1704656:DIAGNOSIS [Research Activity]

Phrase: "is"

Phrase: "post mortem"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0004398:postmortem [Diagnostic Procedure]
  1000   C0580205:Postmortem [Temporal Concept]
  1000   C0848632:post mortem [Finding]
   861   C0687676:Post [Temporal Concept]
   861   C1704687:Post [Manufactured Object]
   789 E C1514253:Postal [Functional Concept]

Phrase: "as"

Phrase: "clinically"

Phrase: "many other disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorders [Disease or Syndrome]

Phrase: "manifest with parkinsonism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205319:Manifest [Functional Concept]
   790   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "without Lewy bodies,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "drug-induced parkinsonism,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0270729:PARKINSONISM, DRUG-INDUCED [Pathologic Function]
   901   C0458082:Drug-induced [Functional Concept]
   827   C0013227:Drug [Pharmacologic Substance]
   827   C0205263:Induced [Functional Concept]
   827   C0242422:Parkinsonism [Disease or Syndrome]
   827   C1254351:Drug [Pharmacologic Substance]
   771 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   771 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   734 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "post-encephalytic parkinsonism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "progressive supranuclear palsy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "and"

Phrase: "spinocerebellar ataxia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   861   C0004134:Ataxia [Sign or Symptom]
   789 E C0234366:Ataxic [Sign or Symptom]

Phrase: "(types 2,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0441730:Type 2 [Classification]
   861   C0332307:Types [Qualitative Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.19: A caveat is that many other diseases exhibit Lewy body pathology, including dementia with Lewy bodies, multiple system atrophy, neurodegeneration with brain iron accumulation I, Down syndrome and, occasionally, prion disorders (711). 

Phrase: "A caveat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871599:Caveat [Governmental or Regulatory Activity]

Phrase: "is"

Phrase: "that"

Phrase: "many other diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "Lewy body pathology,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]
   734   C0085200:Lewy Body [Cell Component]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "dementia with Lewy bodies,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "multiple system atrophy,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "neurodegeneration with brain iron accumulation I,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "Down syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "and"

Phrase: ","

Phrase: "occasionally,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Occasionally [Temporal Concept]

Phrase: "prion disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "(711"

Phrase: ")."
Processing 00000000.tx.20: Relatively little is known regarding the mechanism of PD pathogenesis, in particular the apparent susceptibility of nigral neurons to degeneration. 

Phrase: "Relatively little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   861   C0700321:Little [Quantitative Concept]
   861   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "regarding"

Phrase: "the mechanism of PD pathogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "in particular"

Phrase: "the apparent susceptibility of nigral neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0012655:Susceptibility [Clinical Attribute]
   753   C0220898:Susceptibility [Organism Attribute]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "to degeneration."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011164:Degeneration [Pathologic Function]
  1000   C1880269:Degeneration [Functional Concept]
Processing 00000000.tx.21: Most cases of PD appear sporadic and perhaps are associated with a range of environmental risk factors (reviewed in 12). 

Phrase: "Most cases of PD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "sporadic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205422:Sporadic [Temporal Concept]

Phrase: "and"

Phrase: "perhaps"

Phrase: "are"

Phrase: "associated with a range of environmental risk factors"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   800   C0686732:environmental risk factors [Qualitative Concept]
       E   Environmental Factor
   770   C0035648:risk factors [Quantitative Concept]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1553898:risk factors [Idea or Concept]
   767   C1516998:Environmental Factors [Functional Concept]
   750   C0960756:factor A [Organic Chemical]
   744   C0014406:Environmental [Spatial Concept]
   744   C0035647:Risk [Qualitative Concept]
   744   C1514721:Range [Quantitative Concept]
   744   C2348147:Range [Quantitative Concept]
   744   C3542016:Range [Intellectual Product]
   711 E C0750490:Associate [Idea or Concept]
   711   C1521761:Factor [Functional Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
   711   C2827422:Factor [Conceptual Entity]

Phrase: "("

Phrase: "reviewed in 12"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.22: However, recent studies have demonstrated the importance of genetic contributions to PD and parkinsonism and may provide mechanistic detail of disease pathogenesis (reviewed in 13,14). 

Phrase: "However,"

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "the importance of genetic contributions"

Phrase: "to PD"

Phrase: "and"

Phrase: "parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "and"

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "mechanistic detail of disease pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1522508:Detail [Qualitative Concept]
   760   C1561567:detail [Functional Concept]

Phrase: "("

Phrase: "reviewed in 13,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.23: Indeed, 10 loci have currently been identified as associated with PD (Table 1). 

Phrase: "Indeed,"

Phrase: "10 loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "have"

Phrase: "currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "as"

Phrase: "associated with PD (Table 1"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0039224:Table [Manufactured Object]
   760   C1706073:Table [Medical Device]
   760   C1706074:Table [Intellectual Product]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.24: -synuclein (SNCA) was the first gene linked to PD, the protein being thought to play an essential role in synaptic transmission. 

Phrase: "-synuclein (SNCA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "the first gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "linked to PD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1517892:Link [Intellectual Product]
   756   C1704666:Link [Intellectual Product]

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "being"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an essential role in synaptic transmission."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.25: An alanine to threonine conversion at amino acid 53 (A53T) was identified in a large Greek/Italian kindred with early-onset familial PD (15). 

Phrase: "An alanine to threonine conversion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "at amino acid 53 (A53T)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "identified in a large Greek/Italian"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0022275:ITALIAN [Language]
   753   C0205396:Identified [Qualitative Concept]
   753   C0337806:GREEK [Population Group]
   753   C0337810:Italian [Population Group]
   753   C0549177:Large [Quantitative Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]

Phrase: "kindred with early-onset familial PD (15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0598429:kindred [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.26: In addition, alanine to proline (A30P) and glutamic acid to lysine (E46K) alterations in -synuclein have been identified in rare familial PD kindreds (16,17). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "alanine to proline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A30P"

Phrase: ")"

Phrase: "and"

Phrase: "glutamic acid to lysine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   833   C0523665:Glutamic Acid [Laboratory Procedure]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]

Phrase: "(E46K"

Phrase: ")"

Phrase: "alterations in -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "been"

Phrase: "identified in rare familial PD kindreds"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0015576:familial [Family Group]
   753   C0205396:Identified [Qualitative Concept]
   753   C0241888:Familial [Functional Concept]
   753   C0521114:Rare [Temporal Concept]
   753   C0522498:Rare [Qualitative Concept]
   753   C0598429:kindreds [Qualitative Concept]
   753   C1514917:RARE [Gene or Genome]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]

Phrase: "(16,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.27: Dominant families with SNCA genomic multiplication, triplication and duplications, illustrate that overexpression of the wild-type protein is sufficient for disease; 

Phrase: "Dominant families with SNCA genomic multiplication,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1336547:Synuclein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0015576:Families [Family Group]
   753   C1704727:Family [Conceptual Entity]

Phrase: "triplication"

Phrase: "and"

Phrase: "duplications,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332597:duplications [Functional Concept]
   966 E C1705960:Duplication [Cell or Molecular Dysfunction]

Phrase: "illustrate"

Phrase: "that overexpression of the wild-type protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "is"

Phrase: "sufficient for disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205410:Sufficient [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.28: age at onset and disease severity is associated with copy number (1820). 

Phrase: "age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "disease severity"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0521117:disease severity [Qualitative Concept]
   861   C0439793:Severity [Qualitative Concept]
   861   C2983285:Severity [Intellectual Product]
   789 E C0205082:Severe [Qualitative Concept]

Phrase: "is"

Phrase: "associated with copy number"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1707513:Copy Number [Quantitative Concept]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]
   770   C1948062:Copy [Manufactured Object]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(1820"

Phrase: ")."
Processing 00000000.tx.29: Subsequently, alterations in the promoter of SNCA were shown to be associated with an increased risk of idiopathic PD (21), illustrating how results obtained from rare familial cases may have broader application. 

Phrase: "Subsequently,"

Phrase: "alterations in the promoter of SNCA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]

Phrase: "were"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with an increased risk of idiopathic PD (21"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   742   C0035647:Risk [Qualitative Concept]
   742   C0205217:Increased [Quantitative Concept]
   742   C0332240:Idiopathic [Functional Concept]
   742   C0442805:Increased [Functional Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")"

Phrase: ","

Phrase: "illustrating"

Phrase: "how results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "obtained from rare familial cases"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   760   C0521114:Rare [Temporal Concept]
   760   C0522498:Rare [Qualitative Concept]
   760   C0868928:Cases [Functional Concept]
   760   C1301820:Obtained [Functional Concept]
   760   C1514917:RARE [Gene or Genome]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]
   726 E C1706701:Obtain [Activity]

Phrase: "may"

Phrase: "have"

Phrase: "broader application."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0185125:Application [Health Care Activity]
   861   C1947919:Application [Intellectual Product]
   861   C2347934:Application [Intellectual Product]
   861   C3539080:APPLICATION [Quantitative Concept]
Processing 00000000.tx.30: Several other genes, in addition to parkin (described below) also have been implicated in PD (Table 1). 

Phrase: "Several"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439064:Several [Quantitative Concept]
  1000   C0443302:Several [Quantitative Concept]

Phrase: "other genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "in addition to parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "described below"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: ")"

Phrase: "also"

Phrase: "have"

Phrase: "been"

Phrase: "implicated in PD (Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0039224:Table [Manufactured Object]
   760   C1706073:Table [Medical Device]
   760   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.31: Interestingly, several of these genes are linked to the ubiquitin proteasome system (UPS), suggesting protein metabolism may play a key role in disease pathogenesis. 

Phrase: "Interestingly,"

Phrase: "several of these genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439064:Several [Quantitative Concept]
   770   C0443302:Several [Quantitative Concept]

Phrase: "are"

Phrase: "linked to the ubiquitin proteasome system (UPS),"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0449913:System [Functional Concept]
   753   C1325620:proteasome [Cell Component]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   753   C1752727:Proteasome [Molecular Function]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "protein metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0597299:Protein Metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a key role in disease pathogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.32: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.33: Loci and genes linked to familial Parkinson's disease (OMIM #168600)   PARKIN-PROVEN PD: CLINICAL AND PATHOLOGICAL FEATURES TOP ABSTRACT INTRODUCTION PARKIN-PROVEN PD: CLINICAL AND... 

Phrase: "Loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708726:Locus [Gene or Genome]

Phrase: "and"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "linked to familial Parkinson's disease"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   806   C0030567:Parkinson Disease [Disease or Syndrome]
   806   C1521736:Parkinson's Disease [Functional Concept]
   806   C2681933:PARKINSON DISEASE [Gene or Genome]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "(OMIM #168600"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0950133:OMIM [Intellectual Product]

Phrase: ")"

Phrase: "PARKIN-PROVEN PD"

Phrase: ":"

Phrase: "CLINICAL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "AND"

Phrase: "PATHOLOGICAL FEATURES TOP ABSTRACT INTRODUCTION PARKIN-PROVEN PD"

Phrase: ":"

Phrase: "CLINICAL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "AND..."
Processing 00000000.tx.34: PARKIN: MOLECULAR GENETICS PARKIN GENOMIC ORGANIZATION PARKIN, AN E3 UBIQUITIN... 

Phrase: "PARKIN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "MOLECULAR GENETICS PARKIN GENOMIC ORGANIZATION PARKIN,"

Phrase: "AN E3 UBIQUITIN..."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.35: MODELS OF PARKIN FUNCTION CONCLUSIONS REFERENCES  Mutations in the parkin gene (PRKN) have been associated with autosomal recessive, juvenile onset PD (22). 

Phrase: "MODELS OF PARKIN FUNCTION CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Models [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mutations in the parkin gene (PRKN)"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "associated with autosomal recessive,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0441748:Autosomal recessive [Intellectual Product]
   770   C0596142:autosomal [Cell Component]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "juvenile onset PD (22"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C3149653:Juvenile onset [Finding]
   812   C0332162:Onset [Qualitative Concept]
   812   C3146221:Juvenile [Age Group]

Phrase: ")."
Processing 00000000.tx.36: Parkin-proven disease, caused by homozygous or compound heterozygous mutations of PRKN, has similar cardinal signs as PD, although onset is earlier (<45 years). 

Phrase: "Parkin-proven disease,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "caused by homozygous"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0019904:Homozygous [Organism Attribute]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]

Phrase: "or"

Phrase: "compound heterozygous mutations of PRKN,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "has"

Phrase: "similar cardinal signs as PD,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0220912:signs [Functional Concept]
   760   C0220913:signs [Manufactured Object]
   760   C0311392:SIGNS [Finding]
   760   C0326926:Cardinal [Bird]
   760   C2700598:cardinal [Fungus]
   726 E C1547188:Sign [Idea or Concept]

Phrase: "although"

Phrase: "onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "is"

Phrase: "earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "("

Phrase: "<45 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.37: Additional clinical features include dystonia, pronounced diurnal fluctuation and sleep benefit (23). 

Phrase: "Additional clinical features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1521970:Feature [Qualitative Concept]
   793   C1706388:Feature [Conceptual Entity]
   793   C2346469:Feature [Qualitative Concept]
   793   C2348519:Feature [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "dystonia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013421:Dystonia [Sign or Symptom]
  1000   C0393593:Dystonia [Disease or Syndrome]

Phrase: "pronounced"

Phrase: "diurnal fluctuation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1970037:Diurnal fluctuation [Finding]
   861   C0231239:Fluctuation [Sign or Symptom]
   861   C0231241:Fluctuation [Temporal Concept]
   861   C2827773:Fluctuation% [Qualitative Concept]

Phrase: "and"

Phrase: "sleep benefit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0814225:Benefit [Quantitative Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.38: The dystonia may be a feature of early age of onset rather than parkin mutations per se (24). 

Phrase: "The dystonia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013421:Dystonia [Sign or Symptom]
  1000   C0393593:Dystonia [Disease or Syndrome]

Phrase: "may"

Phrase: "be"

Phrase: "a feature of early age of onset"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1521970:Feature [Qualitative Concept]
   748   C1706388:Feature [Conceptual Entity]
   748   C2346469:Feature [Qualitative Concept]
   748   C2348519:Feature [Qualitative Concept]

Phrase: "rather than"

Phrase: "parkin mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "per se"

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.39: Co-existing morbidity may manifest as depression or psychiatric disturbance (25,26). 

Phrase: "Co-existing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2987476:Exist [Conceptual Entity]

Phrase: "morbidity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026538:Morbidity [Quantitative Concept]
  1000   C0220880:morbidity [Intellectual Product]

Phrase: "may"

Phrase: "manifest as depression"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0011570:Depression [Mental or Behavioral Dysfunction]
   790   C0011581:Depression [Mental or Behavioral Dysfunction]
   790   C0205319:Manifest [Functional Concept]
   790   C0344315:Depression [Finding]
   790   C0349217:depression nos [Mental or Behavioral Dysfunction]
   790   C0460137:Depression [Functional Concept]
   718 E C0549249:DEPRESSED [Finding]

Phrase: "or"

Phrase: "psychiatric disturbance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2699787:Disturbance [Qualitative Concept]

Phrase: "(25,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.40: Given that loss of parkin function is causal, there is considerable disparity in age of onset, presentation, progression and response to drug treatment, even for patients within the same sibship, with the same mutations (24,27). 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that loss of parkin function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "is"

Phrase: "causal, there"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   789   C0015127:causality [Functional Concept]
   789   C1314792:Causalities [Functional Concept]

Phrase: "is"

Phrase: "considerable disparity in age of onset,"

Phrase: "presentation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449450:Presentation [Idea or Concept]

Phrase: "progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242656:progression [Pathologic Function]
  1000   C0449258:Progression [Functional Concept]

Phrase: "and"

Phrase: "response to drug treatment,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   909   C0683154:response to drug [Organism Function]
           drug response
   881   C0521982:Response to treatment [Clinical Attribute]
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "even for patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "within the same sibship,"

Phrase: "with the same mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(24,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.41: Treatment is similar to PD with a good response to low doses of levodopa, although dyskinesias may be early and problematic to manage given the duration of disease. 

Phrase: "Treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "is"

Phrase: "similar to PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "with a good response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "to low doses"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0445550:Low dose [Quantitative Concept]
   983   C1708745:Low-Dose [Research Activity]
   861   C0178602:Doses [Quantitative Concept]
   827 E C0869039:Dose [Quantitative Concept]
   827 E C1114758:Dose # [Clinical Attribute]
   827 E C1428722:DOS [Gene or Genome]

Phrase: "of levodopa,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0023570:Levodopa [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   944 E C0699991:Larodopa [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   944 E C0720022:Dopar [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "although"

Phrase: "dyskinesias"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013384:Dyskinesias [Disease or Syndrome]

Phrase: "may"

Phrase: "be"

Phrase: "early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "problematic to"

Phrase: "manage"

Phrase: "given"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]

Phrase: "the duration of disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0872146:disease duration [Temporal Concept]
   770   C0449238:Duration [Temporal Concept]
   770   C2926735:Duration [Pharmacologic Substance]
Processing 00000000.tx.42: To date, there have been few reports of detailed pathology in parkin-proven disease cases (<8). 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "there"

Phrase: "have"

Phrase: "been"

Phrase: "few"

Phrase: "reports of detailed pathology"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   819   C0807321:Pathology report [Intellectual Product]
   770   C0030664:Pathology [Biomedical Occupation or Discipline]
   770   C0205469:pathology [Functional Concept]
   770   C0677042:pathology [Pathologic Function]
   770   C0684224:Report [Intellectual Product]
   770   C0700287:Report [Health Care Activity]
   770   C1522508:Detailed [Qualitative Concept]
   770   C3273238:Report [Intellectual Product]

Phrase: "in parkin-proven disease cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]

Phrase: "("

Phrase: "<8"

Phrase: ")."
Processing 00000000.tx.43: Pathologically, patients with homozygous deletion of PRKN demonstrated profound neuronal loss of dopaminergic neurons in the substantia nigra and locus ceruleus (2831). 

Phrase: "Pathologically,"

Phrase: "patients with homozygous deletion of PRKN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030705:Patients [Patient or Disabled Group]

Phrase: "demonstrated"

Phrase: "profound neuronal loss of dopaminergic neurons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   846   C3550005:Loss of dopaminergic neurons [Finding]
   797   C0598940:Loss of neurons [Finding]
       E   neuron loss
   790   C1850496:Neuronal loss [Finding]
   753   C1517945:Loss [Quantitative Concept]

Phrase: "in the substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "locus ceruleus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023951:Locus Caeruleus [Body Part, Organ, or Organ Component]
  1000   C1289445:Locus ceruleus [Body Part, Organ, or Organ Component]
   861   C1708726:Locus [Gene or Genome]

Phrase: "(2831"

Phrase: ")."
Processing 00000000.tx.44: In notable contrast to idiopathic PD, Lewy bodies (LBs) were not observed, perhaps suggesting that functional parkin is a prerequisite for LB generation (32). 

Phrase: "In notable contrast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1979874:Contrast [Qualitative Concept]

Phrase: "to idiopathic PD,"

Phrase: "Lewy bodies (LBs)"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "perhaps"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that functional parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a prerequisite for LB generation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0679209:prerequisite [Idea or Concept]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.45: Lewy bodies are thought to represent a mechanism whereby cells sequester damaged and toxic proteins in an inactive form. 

Phrase: "Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "are"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a mechanism whereby cells sequester"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0333312:sequester [Functional Concept]

Phrase: "damaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0010957:Damage [Injury or Poisoning]
   966   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "toxic proteins in an inactive form."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0815048:toxic proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.46: The UPS is involved in the detoxification of toxic proteins, so complete loss of parkin (a component of the UPS, see below) may be sufficient to prevent LB formation. 

Phrase: "The UPS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0449913:System [Functional Concept]
   827   C1325620:proteasome [Cell Component]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1752727:Proteasome [Molecular Function]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "is"

Phrase: "involved in the detoxification of toxic proteins,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0815048:toxic proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0025516:Detoxification [Organism Function]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0150543:Detoxification [Therapeutic or Preventive Procedure]
   748   C0600688:toxic [Injury or Poisoning]
   748   C1314939:Involved [Functional Concept]
   748   C1407029:Toxic [Qualitative Concept]

Phrase: "so"

Phrase: "complete loss of parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "("

Phrase: "a component of the UPS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")"

Phrase: "may"

Phrase: "be"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "LB formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]
Processing 00000000.tx.47: In contrast, some patients with compound heterozygous PRKN mutations have been described with Lewy body or tau pathology (3335). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "some patients with compound heterozygous PRKN mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0030705:Patients [Patient or Disabled Group]

Phrase: "have"

Phrase: "been"

Phrase: "described with Lewy body"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0085200:Lewy Body [Cell Component]
   770   C0242821:body [Human]
   770   C0460148:Body [Anatomical Structure]
   770   C1268086:Body [Anatomical Structure]
   770   C1552738:described [Idea or Concept]

Phrase: "or"

Phrase: "tau pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "(3335"

Phrase: ")."
Processing 00000000.tx.48: Recent studies have shown missense mutations within RING domains retain ubiquitin ligase activity (36) and confer a toxic gain of function, leading to parkin protein aggregation and aggresome formation (37,38). 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "missense mutations within RING domains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0599155:Mutations, Missense [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "ubiquitin ligase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150685:ubiquitin-ligase activity [Molecular Function]
   913   C1325411:ubiquitin activity [Molecular Function]
   901   C1150651:ligase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "(36"

Phrase: ")"

Phrase: "and"

Phrase: "confer"

Phrase: "a toxic gain of function,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517378:Gain [Quantitative Concept]

Phrase: "leading"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332152:Leading [Temporal Concept]
  1000   C1522538:Leading [Functional Concept]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to parkin protein aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332621:Aggregation [Functional Concept]
   812   C0439168:% aggregation [Quantitative Concept]
   741 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "aggresome formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(37,"

Phrase: "38"

Phrase: ")."
Processing 00000000.tx.49: These results may help explain the alternate pathologies observed post mortem.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "may"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "explain"

Phrase: "the alternate pathologies"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0030664:Pathologies [Biomedical Occupation or Discipline]
   827 E C0205469:pathology [Functional Concept]
   827 E C0677042:pathology [Pathologic Function]
   777 E C1521733:Pathologic [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "post mortem."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0004398:postmortem [Diagnostic Procedure]
  1000   C0580205:Postmortem [Temporal Concept]
  1000   C0848632:post mortem [Finding]
   861   C0687676:Post [Temporal Concept]
   861   C1704687:Post [Manufactured Object]
   789 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.50: PARKIN: MOLECULAR GENETICS TOP ABSTRACT INTRODUCTION PARKIN-PROVEN PD: CLINICAL AND... 

Phrase: "PARKIN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "MOLECULAR GENETICS TOP ABSTRACT INTRODUCTION PARKIN-PROVEN PD"

Phrase: ":"

Phrase: "CLINICAL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "AND..."
Processing 00000000.tx.51: PARKIN: MOLECULAR GENETICS PARKIN GENOMIC ORGANIZATION PARKIN, AN E3 UBIQUITIN... 

Phrase: "PARKIN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "MOLECULAR GENETICS PARKIN GENOMIC ORGANIZATION PARKIN,"

Phrase: "AN E3 UBIQUITIN..."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.52: MODELS OF PARKIN FUNCTION CONCLUSIONS REFERENCES  Parkin is one of the largest genes in the genome. 

Phrase: "MODELS OF PARKIN FUNCTION CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Models [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "one of the largest genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "in the genome."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017428:Genome [Gene or Genome]
  1000   C2338314:Genome [Conceptual Entity]
Processing 00000000.tx.53: The gene has 12 exons, encoding 465 amino acids, with a super-expanded intronic structure spanning 1.3Mb of genomic DNA (22,39) (Fig.1). 

Phrase: "The gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "has"

Phrase: "12 exons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "465 amino acids,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "with a super-expanded intronic structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0678594:Structure [Spatial Concept]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "1.3Mb of genomic DNA (22,"

Phrase: "39"

Phrase: ")"

Phrase: "(Fig.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.54: The parkin locus (PRKN), adjacent to the 6q telomere is hyper-recombinable and lies within FRA6E, the third most common fragile site in tumor tissue (40,41), although the potential role of parkin in cancer is yet to be determined. 

Phrase: "The parkin locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "(PRKN"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "adjacent to the 6q telomere"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "is"

Phrase: "hyper-recombinable"

Phrase: "and"

Phrase: "lies within FRA6E,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1414780:FRA6E [Gene or Genome]

Phrase: "the third most common fragile site in tumor tissue"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0677504:Fragile Site [Nucleotide Sequence]
   762   C0475445:Tumor site [Spatial Concept]
   762   C1333132:Common Tumor [Neoplastic Process]
   742   C0205145:Site [Spatial Concept]
   742   C0205214:Common [Quantitative Concept]
   742   C1515974:Site [Body Location or Region]
   742   C1522138:Common [Functional Concept]
   742   C2825164:Site [Spatial Concept]
   742   C3245511:common [Intellectual Product]

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "the potential role of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in cancer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "is"

Phrase: "yet to"

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.55: View larger version (27K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.56: Schematic representation of the Parkin/PACRG locus. 

Phrase: "Schematic representation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514861:Representation [Conceptual Entity]
   861   C1882932:Representation [Activity]

Phrase: "of the Parkin/PACRG locus."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   857   C1418270:parkin gene [Gene or Genome]
           PARKIN
   857   C2983548:Parkin Gene [Gene or Genome]
   804   C1708726:Gene Locus [Gene or Genome]
           Locus
   790   C0017337:Gene [Gene or Genome]
   790   C0332285:Of [Spatial Concept]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.57: The chromosomal location is shown (left). 

Phrase: "The chromosomal location"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450429:Location [Spatial Concept]
   861   C1515974:Location [Body Location or Region]

Phrase: "is"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")."
Processing 00000000.tx.58: Individual exons are shown (not to scale) with intron sizes indicated (middle). 

Phrase: "Individual exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "("

Phrase: "not to scale"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0175659:Scale [Medical Device]
   790   C0349674:Scale [Intellectual Product]
   790   C1518422:Not [Functional Concept]
   790   C1947916:Scale [Activity]
   790   C3536777:Scale [Manufactured Object]
   718 E C1710017:Scalar [Qualitative Concept]
   706 E C0222045:Scales [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "with intron sizes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:SIZES [Spatial Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "(middle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0444598:Middle [Spatial Concept]
  1000   C0549183:middle [Spatial Concept]
  1000   C1552826:middle [Idea or Concept]
   944 E C0205098:Medial [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.59: A model of the protein domain structure and location of known exon rearrangements is indicated (right).  

Phrase: "A model of the protein domain structure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1554088:Domain model [Idea or Concept]
   748   C3161035:Model [Intellectual Product]
   738   C0026349:Structural Model [Manufactured Object]

Phrase: "and"

Phrase: "location of known exon rearrangements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0450429:Location [Spatial Concept]
   760   C1515974:Location [Body Location or Region]

Phrase: "is"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.60: The initial parkin mutations identified were large homozygous genomic deletions, however subsequent studies also identified multiplications, small deletion/insertions and missense mutations (reviewed in 42; Table 2). 

Phrase: "The initial parkin mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "were"

Phrase: "large homozygous genomic deletions,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C1880274:Deletions [Activity]
   779 E C1442161:Deletion [Cell or Molecular Dysfunction]
   779 E C1511760:Deletion [Genetic Function]

Phrase: "however subsequent studies also identified multiplications,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C2911648:Multiplication [Quantitative Concept]

Phrase: "small deletion/insertions"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441587:insertions [Health Care Activity]
   793 E C0021107:Insertion [Therapeutic or Preventive Procedure]
   793 E C1512796:Insertion [Genetic Function]
   793 E C1883719:Insertion [Functional Concept]

Phrase: "and"

Phrase: "missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0599155:Mutations, Missense [Genetic Function]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "("

Phrase: "reviewed in 42"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "; Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.61: PRKN semi-quantitative genomic dosage assays and sequence analysis has been performed in familial and sporadic early-onset parkinsonism (<45 years at onset) (24,26,4347). 

Phrase: "PRKN semi-quantitative genomic dosage assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0005507:Assay [Laboratory Procedure]
   762   C0243073:assay [Qualitative Concept]
   762   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "sequence analysis"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C0936012:Analysis [Research Activity]
   861   C1519249:Sequence [Functional Concept]
   861   C1524024:analysis [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "performed in familial"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0015576:familial [Family Group]
   790   C0241888:Familial [Functional Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]
   718 E C1704727:Family [Conceptual Entity]

Phrase: "and"

Phrase: "sporadic early-onset parkinsonism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1838631:Parkinsonism, early-onset [Finding]
   812   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "("

Phrase: "<45 years at onset"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439234:years [Temporal Concept]
   737 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "(24,"

Phrase: "26,"

Phrase: "4347"

Phrase: ")."
Processing 00000000.tx.62: The likelihood of PRKN mutations is inversely associated with age and may be as high as 50% in individuals with parkinsonism at age <25 years (24,47). 

Phrase: "The likelihood of PRKN mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033204:Likelihood [Quantitative Concept]

Phrase: "is"

Phrase: "inversely"

Phrase: "associated with age"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0001779:Age [Organism Attribute]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "may"

Phrase: "be"

Phrase: "as"

Phrase: "high as 50%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205250:High [Qualitative Concept]
   790   C1299351:High [Qualitative Concept]
   790   C2700149:HIGH [Intellectual Product]

Phrase: "in individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0027361:Individual [Population Group]
   966   C0237401:Individual [Human]

Phrase: "with parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "at age <25 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C1510829:Age-Years [Temporal Concept]
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: "(24,"

Phrase: "47"

Phrase: ")."
Processing 00000000.tx.63: In only a few instances has the effect of truncated or missense mutations on parkin cDNA or protein expression or activity been demonstrated and more work is required. 

Phrase: "In only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a few instances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550608:Instance [Idea or Concept]

Phrase: "has"

Phrase: "the effect of truncated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "missense mutations on parkin cDNA"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0599155:Mutations, Missense [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1171362:protein expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "been"

Phrase: "demonstrated"

Phrase: "and"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "is"

Phrase: "required."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]
Processing 00000000.tx.64: Exonic rearrangements (deletions/duplications) tend to arise de novo, whereas the majority of missense mutations are related to a common founder (27,45). 

Phrase: "Exonic rearrangements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511695:Rearrangements [Genetic Function]

Phrase: "(deletions/duplications"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C3258811:deletion+duplication [Finding]
   861   C0332597:duplications [Functional Concept]
   827 E C1705960:Duplication [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "tend"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "arise"

Phrase: "de novo,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1515568:de novo [Idea or Concept]
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "whereas"

Phrase: "the majority of missense mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "are"

Phrase: "related to a common founder"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0205214:Common [Quantitative Concept]
   760   C0263541:Founder [Disease or Syndrome]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1522138:Common [Functional Concept]
   760   C3245511:common [Intellectual Product]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "(27,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.65: Compound heterozygous mutations, with deletion and missense mutations, explain the majority of cases with early-onset parkinsonism (<45 years at onset). 

Phrase: "Compound heterozygous mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "with deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "and"

Phrase: "missense mutations,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0599155:Mutations, Missense [Genetic Function]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "explain"

Phrase: "the majority of cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "with early-onset parkinsonism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1838631:Parkinsonism, early-onset [Finding]
   827   C0242422:Parkinsonism [Disease or Syndrome]
   734   C1833334:Early-onset [Finding]

Phrase: "("

Phrase: "<45 years at onset"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439234:years [Temporal Concept]
   737 E C0439508:/year [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.66: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.67: Mutations and polymorphisms in the coding region of parkin gene  Screening the PRKN gene represents a formidable challenge (46) and thus limited genetic epidemiological data is available on the population frequency of exonic deletion/duplication and missense mutations within controls and idiopathic (late-onset) Parkinson's disease (48). 

Phrase: "Mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "polymorphisms in the coding region of parkin gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0678951:gene polymorphisms [Genetic Function]
   744   C0032529:polymorphisms [Genetic Function]
   711 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "Screening"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0220908:Screening [Health Care Activity]
  1000   C0220909:screening [Functional Concept]
  1000   C1698960:screening [Intellectual Product]
  1000   C1710031:Screening [Diagnostic Procedure]
  1000   C1710477:SCREENING [Research Activity]
   966 E C1305399:screen [Functional Concept]
   966 E C1705053:Screen [Medical Device]

Phrase: "the PRKN gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C1418270:parkin gene [Gene or Genome]
   734   C2983548:Parkin Gene [Gene or Genome]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a formidable challenge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0798503:Challenge [Clinical Attribute]
   861   C0805586:Challenge [Health Care Activity]
   861   C3274764:Challenge [Conceptual Entity]

Phrase: "(46"

Phrase: ")"

Phrase: "and"

Phrase: "thus"

Phrase: "limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "genetic epidemiological data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "is"

Phrase: "available on the population frequency of exonic deletion/duplication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0470187:Available [Functional Concept]
           Availability of

Phrase: "and"

Phrase: "missense mutations within controls"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0599155:Mutations, Missense [Genetic Function]
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "idiopathic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332240:Idiopathic [Functional Concept]

Phrase: "(late-onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205087:Late [Temporal Concept]
   861   C0332162:Onset [Qualitative Concept]

Phrase: ")"

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.68: To date, community-based studies suggest that carrier status (heterozygous loss of parkin function) is not causal for early-onset disease although some promoter and coding polymorphisms have been associated with late-onset PD (24,42,44,48). 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "community-based studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that carrier status"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449439:Carrier status [Finding]
   861   C0449438:Status [Qualitative Concept]

Phrase: "(heterozygous loss of parkin function"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C0524869:Loss of Heterozygosity [Genetic Function]
           Heterozygosity Loss
   760   C1517945:Loss [Quantitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "not causal for early-onset disease"

Phrase: "although"

Phrase: "some promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "coding polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "associated with late-onset PD (24,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0205087:Late [Temporal Concept]
   753   C0332162:Onset [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "42,"

Phrase: "44,"

Phrase: "48"

Phrase: ")."
Processing 00000000.tx.69: Genetic testing is now warranted for a number of heritable disorders where information on mutation status may provide a positive impact on individuals' need to know, inform lifestyle or reproductive choices. 

Phrase: "Genetic testing"
Meta Candidates (Total=20; Excluded=15; Pruned=0; Remaining=5)
  1000   C0679560:Genetic Testing [Laboratory Procedure]
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0039593:Testing [Functional Concept]
   861   C0314603:Genetic [Functional Concept]
   861   C0392366:testing [Intellectual Product]
   827 E C0022885:Test [Laboratory Procedure]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "is"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "warranted for a number of heritable disorders where information"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0019247:heritable disorder [Disease or Syndrome]
   742   C0012634:Disorders [Disease or Syndrome]
   742   C0237753:*Number [Quantitative Concept]
   742   C0439660:Heritable [Functional Concept]
   742   C0449788:Number [Quantitative Concept]
   742   C1533716:Information [Idea or Concept]

Phrase: "on mutation status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449438:Status [Qualitative Concept]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a positive impact on individuals'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1825598:IMPACT [Gene or Genome]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "know"

Phrase: ","

Phrase: "inform"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0700287:inform [Health Care Activity]
  1000   C1552002:inform [Idea or Concept]

Phrase: "lifestyle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023676:Life Style [Social Behavior]

Phrase: "or"

Phrase: "reproductive choices."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0008300:choices [Individual Behavior]
   827 E C1707391:Choice [Activity]
Processing 00000000.tx.70: Where testing is offered, positive and negative results are largely unequivocal and meaningful genetic counseling can be offered. 

Phrase: "Where testing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039593:Testing [Functional Concept]
   861   C0392366:testing [Intellectual Product]

Phrase: "is"

Phrase: "offered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444648:Offered [Finding]

Phrase: ","

Phrase: "positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439178:% Positive [Quantitative Concept]
  1000   C1446409:Positive [Qualitative Concept]
  1000   C1514241:Positive [Finding]
  1000   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "negative results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "are"

Phrase: "largely unequivocal"

Phrase: "and"

Phrase: "meaningful genetic counseling"
Meta Candidates (Total=20; Excluded=14; Pruned=0; Remaining=6)
   901   C0017382:Genetic Counseling [Therapeutic or Preventive Procedure]
   827   C0010210:Counseling [Health Care Activity]
   827   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   827   C0314603:Genetic [Functional Concept]
   827   C0341618:Counselling [Professional or Occupational Group]
   827   C0740209:Counseling NOS [Finding]
   771 E C0005615:Birth [Organism Function]
   771 E C0035150:Reproduction [Organism Function]
   771 E C0079946:origin [Classification]
   771 E C0439659:Origin [Temporal Concept]
   771 E C1550512:origin [Intellectual Product]
   771 E C1550722:birth [Idea or Concept]
   771 E C3245487:birth [Intellectual Product]
   743 E C0454729:Natal [Geographic Area]
   743 E C0559522:Genital [Body System]
   743 E C1546649:Genital [Intellectual Product]
   743 E C1550642:Genital [Body Substance]
   734 E C0205313:Original [Idea or Concept]
   734 E C2347409:Original [Occupational Activity]
   716 E C0598240:originality [Mental Process]

Phrase: "can"

Phrase: "be"

Phrase: "offered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444648:Offered [Finding]
Processing 00000000.tx.71: Any test must consider three separate issues: interpretation, quality control and utility. 

Phrase: "Any test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "must"

Phrase: "consider"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:consider [Idea or Concept]

Phrase: "three separate issues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0033213:Issue [Finding]
   793   C1706387:Issue [Intellectual Product]

Phrase: ":"

Phrase: "interpretation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0459471:Interpretation [Intellectual Product]
  1000   C3173575:Interpretation [Clinical Attribute]

Phrase: "quality control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0034378:quality control [Functional Concept]
  1000   C1561524:Quality Control [Intellectual Product]
  1000   C1610034:Quality Control [Intellectual Product]
   861   C0243148:control [Qualitative Concept]
   861   C0332306:Quality [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "utility."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582205:utility [Organization]
Processing 00000000.tx.72: For PRKN, functional and frequency data is limited and presently inadequate to inform a diagnosis. 

Phrase: "For PRKN,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "functional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205245:Functional [Functional Concept]
  1000   C0542341:Functional [Functional Concept]
  1000   C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "frequency data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "is"

Phrase: "limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "and"

Phrase: "presently inadequate to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205412:Inadequate [Qualitative Concept]
   827   C0750528:presently [Idea or Concept]

Phrase: "inform"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0700287:inform [Health Care Activity]
  1000   C1552002:inform [Idea or Concept]

Phrase: "a diagnosis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]
Processing 00000000.tx.73: Accurate assessment is difficult given the quantitative/sequencing assays required and the size of the gene. 

Phrase: "Accurate assessment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1261322:Assessment [Health Care Activity]
   861   C1516048:Assessment [Activity]

Phrase: "is"

Phrase: "difficult given"

Phrase: "the quantitative/sequencing assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "and"

Phrase: "the size of the gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0456389:size [Spatial Concept]
Processing 00000000.tx.74: The utility is also questionable, except to inform the reproductive choices of consanguineous families. 

Phrase: "The utility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582205:utility [Organization]

Phrase: "is"

Phrase: "also questionable,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332241:Questionable [Qualitative Concept]

Phrase: "except to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inform"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0700287:inform [Health Care Activity]
  1000   C1552002:inform [Idea or Concept]

Phrase: "the reproductive choices of consanguineous families."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0008300:choices [Individual Behavior]
   719 E C1707391:Choice [Activity]
Processing 00000000.tx.75: Hence, commercial genetic testing for PRKN mutations is ill advised. 

Phrase: "Hence,"

Phrase: "commercial genetic testing for PRKN mutations"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0679560:Genetic Testing [Laboratory Procedure]
   774   C0026882:genetic mutations [Genetic Function]
   748   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   748   C0039593:Testing [Functional Concept]
   748   C0314603:Genetic [Functional Concept]
   748   C0392366:testing [Intellectual Product]
   714 E C0022885:Test [Laboratory Procedure]

Phrase: "is"

Phrase: "ill advised."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0231218:Ill [Sign or Symptom]
Processing 00000000.tx.76: As an alternative, patients might be encouraged to participate in de-identified genetic epidemiological research.  

Phrase: "As an alternative,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1523987:Alternative [Conceptual Entity]

Phrase: "patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "might"

Phrase: "be"

Phrase: "encouraged"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "participate in"

Phrase: "de-identified"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C0205396:Identified [Qualitative Concept]
   861   C1550043:Identified [Finding]
   861   C1551388:Identified [Functional Concept]
   861   C3541240:DE [Idea or Concept]

Phrase: "genetic epidemiological research."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   913   C0243064:Genetic Research [Research Activity]
   865   C0002783:Epidemiology Research [Research Activity]
   865   C0872180:Genetic Epidemiologies [Occupation or Discipline]
   827   C0014507:Epidemiological [Biomedical Occupation or Discipline]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   755 E C0014508:epidemiology [Functional Concept]
   755 E C0699910:epidemiology [Health Care Activity]
Processing 00000000.tx.77: PARKIN GENOMIC ORGANIZATION TOP ABSTRACT INTRODUCTION PARKIN-PROVEN PD: CLINICAL AND... 

Phrase: "PARKIN GENOMIC ORGANIZATION TOP ABSTRACT INTRODUCTION PARKIN-PROVEN PD"

Phrase: ":"

Phrase: "CLINICAL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "AND..."
Processing 00000000.tx.78: PARKIN: MOLECULAR GENETICS PARKIN GENOMIC ORGANIZATION PARKIN, AN E3 UBIQUITIN... 

Phrase: "PARKIN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "MOLECULAR GENETICS PARKIN GENOMIC ORGANIZATION PARKIN,"

Phrase: "AN E3 UBIQUITIN..."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.79: MODELS OF PARKIN FUNCTION CONCLUSIONS REFERENCES  The genomic organization and transcriptional regulation of the PRKN locus may also provide insight into function. 

Phrase: "MODELS OF PARKIN FUNCTION CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Models [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The genomic organization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0029237:Organisation [Physiologic Function]
   861   C0029246:Organization [Organization]
   861   C0220885:organization [Qualitative Concept]
   861   C1300196:Organization [Functional Concept]
   861   C1522486:Organization [Professional or Occupational Group]

Phrase: "and"

Phrase: "transcriptional regulation of the PRKN locus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C1710463:Transcription Regulation Gene [Gene or Genome]
   778   C1158770:Transcriptional Regulation [Genetic Function]
   774   C0017263:Gene Regulation [Genetic Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "may"

Phrase: "also"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "insight into function."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0233820:Insight, function [Mental Process]
           Insight
Processing 00000000.tx.80: PRKN has massive introns that must be transcribed to hnRNA, then spliced to give a mature RNA message for subsequent translation (39,49). 

Phrase: "PRKN"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "has"

Phrase: "massive introns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Introns [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "that"

Phrase: "must"

Phrase: "be"

Phrase: "transcribed to hnRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0035695:hn RNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "spliced"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "a mature RNA message for subsequent translation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0470166:Message [Intellectual Product]

Phrase: "(39,"

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.81: The adjacent gene, PACRG, with only five exons encoding 257 amino acids, spans a similar sized genomic distance of 0.6Mb (50). 

Phrase: "The adjacent gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "PACRG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   728   C1418270:parkin gene [Gene or Genome]
   728   C2983548:Parkin Gene [Gene or Genome]

Phrase: "with only five exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "257 amino acids,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "spans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1711300:Span [Conceptual Entity]
  1000   C2700613:Span [Quantitative Concept]

Phrase: "a similar sized genomic distance of 0.6Mb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0012751:Distance [Quantitative Concept]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.82: Both genes share a 204bp promoter being transcribed on opposite DNA strands in opposite orientations. 

Phrase: "Both genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "a 204bp promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "being"

Phrase: "transcribed on opposite DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1521805:Opposite [Spatial Concept]

Phrase: "strands in opposite orientations."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0029266:Orientations [Mental Process]
   770   C1521805:Opposite [Spatial Concept]
   770   C1704972:Strand [Spatial Concept]
       E   Orientation
   770   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
   737 E C1704322:orientation [Spatial Concept]
   737 E C3539923:Orientation [Intellectual Product]
Processing 00000000.tx.83: Given their physical proximity and common transcription factor binding motifs, some degree of co-regulation may be expected (50). 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "their physical proximity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514583:Proximity [Spatial Concept]

Phrase: "and"

Phrase: "common transcription factor binding motifs,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C1149367:transcription factor binding [Genetic Function]
   840   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0040649:Transcription [Genetic Function]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771   C1514562:Motif [Amino Acid Sequence]

Phrase: "some degree of co-regulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.84: However, parkin's unique repression by N-myc is noteworthy (51), not least as it further implicates the protein in cell-cycle regulation and neuronal differentiation (52). 

Phrase: "However,"

Phrase: "parkin's unique repression by N-myc"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035143:Repression [Mental Process]

Phrase: "is"

Phrase: "noteworthy"

Phrase: "(51"

Phrase: ")"

Phrase: ","

Phrase: "not least"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "as"

Phrase: "it further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "implicates"

Phrase: "the protein in cell-cycle regulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C1155872:Cell Cycle Regulation [Cell Function]
   804   C0851285:Regulation [Governmental or Regulatory Activity]
   804   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "neuronal differentiation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1518294:Neuronal Differentiation [Finding]
   964 E C1159970:neuron differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(52"

Phrase: ")."
Processing 00000000.tx.85: The organization of the PRKN/PACRG locus, conserved within vertebrates, is reminiscent of a bacterial operon and suggests functional significance (50). 

Phrase: "The organization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0029237:Organisation [Physiologic Function]
  1000   C0029246:Organization [Organization]
  1000   C0220885:organization [Qualitative Concept]
  1000   C1300196:Organization [Functional Concept]
  1000   C1522486:Organization [Professional or Occupational Group]

Phrase: "of the PRKN/PACRG locus,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   860   C1708726:Gene Locus [Gene or Genome]
           Locus
   801   C1418270:parkin gene [Gene or Genome]
           PARKIN
   801   C2983548:Parkin Gene [Gene or Genome]
   788   C0017337:Gene [Gene or Genome]
   788   C0332285:Of [Spatial Concept]
   788   C0851285:Regulated [Governmental or Regulatory Activity]
   788   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "conserved within vertebrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0042567:Vertebrates [Vertebrate]

Phrase: "is"

Phrase: "reminiscent of a bacterial operon"

Phrase: "and"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "functional significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0237881:Significance [Quantitative Concept]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.86: Interestingly, PACRG is the most recent substrate of parkin to be recognized (see below; 53). 

Phrase: "Interestingly,"

Phrase: "PACRG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   728   C1418270:parkin gene [Gene or Genome]
   728   C2983548:Parkin Gene [Gene or Genome]

Phrase: "is"

Phrase: "the most recent substrate of parkin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710236:Substrate [Manufactured Object]

Phrase: "be"

Phrase: "recognized"

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: "; 53"

Phrase: ")."
Processing 00000000.tx.87: The transcriptional and post-translational regulation of the PRKN/PACRG locus suggests co-ordinate expression is biologically critical.  

Phrase: "The transcriptional"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcriptional [Genetic Function]

Phrase: "and"

Phrase: "post-translational regulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1514251:Post-Translational Regulation [Molecular Function]
   901   C3537096:Translational Regulation [Genetic Function]
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]

Phrase: "of the PRKN/PACRG locus"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   860   C1708726:Gene Locus [Gene or Genome]
           Locus
   801   C1418270:parkin gene [Gene or Genome]
           PARKIN
   801   C2983548:Parkin Gene [Gene or Genome]
   788   C0017337:Gene [Gene or Genome]
   788   C0332285:Of [Spatial Concept]
   788   C0851285:Regulated [Governmental or Regulatory Activity]
   788   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "co-ordinate expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "biologically critical."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511545:Critical [Qualitative Concept]
Processing 00000000.tx.88: PARKIN, AN E3 UBIQUITIN PROTEIN LIGASE TOP ABSTRACT INTRODUCTION PARKIN-PROVEN PD: CLINICAL AND... 

Phrase: "PARKIN,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "AN E3 UBIQUITIN PROTEIN LIGASE TOP ABSTRACT INTRODUCTION PARKIN-PROVEN PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2983549:E3 Ubiquitin-Protein Ligase Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "CLINICAL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "AND..."
Processing 00000000.tx.89: PARKIN: MOLECULAR GENETICS PARKIN GENOMIC ORGANIZATION PARKIN, AN E3 UBIQUITIN... 

Phrase: "PARKIN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "MOLECULAR GENETICS PARKIN GENOMIC ORGANIZATION PARKIN,"

Phrase: "AN E3 UBIQUITIN..."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.90: MODELS OF PARKIN FUNCTION CONCLUSIONS REFERENCES  Shimura et al. 

Phrase: "MODELS OF PARKIN FUNCTION CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Models [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Shimura et al."
Processing 00000000.tx.91: (54) showed parkin was an E3 ubiquitin-protein ligase, with a Ubl domain N' terminus, followed by two RING (Really-Interesting-New-Gene) finger domains separated by an IBR (In-Between-Ring) domain (55). 

Phrase: "(54"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "an E3 ubiquitin-protein ligase,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0077678:E3 Ubiquitin Ligase [Amino Acid, Peptide, or Protein,Enzyme]
           ubiquitin-protein ligase
           E3 Ligase
   923   C1256818:Ubiquitin Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1307637:Ubiquitin-Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1418270:E3 ubiquitin ligase [Gene or Genome]
   923   C1442769:ubiquitin-protein ligase [Gene or Genome]
   812   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "with a Ubl domain N' terminus,"

Phrase: "followed by two RING"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0205448:Two [Quantitative Concept]
   770   C0521164:Ring [Spatial Concept]
   770   C1260969:Ring [Medical Device]
   770   C1705184:Ring [Medical Device]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "(Really-"

Phrase: "Interesting-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "New-Gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: ")"

Phrase: "finger domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "separated by an IBR (In-Between-Ring"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0021334:IBR [Disease or Syndrome]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0521164:Ring [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C1260969:Ring [Medical Device]
   748   C1705184:Ring [Medical Device]

Phrase: ")"

Phrase: "domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.92: The motif of two RING fingers separated by an IBR domain is common to several E3 ligases, enzymes that catalyse the conjugation of activated ubiquitin to target proteins prior to their destruction via the proteasome. 

Phrase: "The motif of two RING fingers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1521759:Ring Finger Motif [Cell Component]
   753   C1514562:Motif [Amino Acid Sequence]

Phrase: "separated by an IBR domain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0021334:IBR [Disease or Syndrome]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "common to several E3 ligases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205214:Common [Quantitative Concept]
   760   C1522138:Common [Functional Concept]
   760   C3245511:common [Intellectual Product]

Phrase: "enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "that"

Phrase: "catalyse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007382:catalyse [Natural Phenomenon or Process]

Phrase: "the conjugation of activated ubiquitin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1160466:conjugation [Cell Function]

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "proteins prior to their destruction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "via the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.93: The identification of parkin as a component of the ubiquitylation cycle strengthens the theory that UPS dysfunction is central to PD pathogenesis. 

Phrase: "The identification of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "as a component"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449432:Component [Manufactured Object]
  1000   C1705248:Component [Conceptual Entity]

Phrase: "of the ubiquitylation cycle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511572:Cycle [Temporal Concept]

Phrase: "strengthens"

Phrase: "the theory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871935:Theory [Idea or Concept]

Phrase: "that UPS dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0031847:dysfunction [Functional Concept]
   812   C0277785:Dysfunction, NOS [Qualitative Concept]
   756 E C0231174:Malfunction [Functional Concept]
   756 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "is"

Phrase: "central to PD pathogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205099:Central [Spatial Concept]
   770   C1879652:Central - [Laboratory Procedure]
Processing 00000000.tx.94: Using different approaches many putative parkin substrates have been identified, including synphilin-1, O-glycosylated -synuclein (-Sp22), CHIP, Pael-R, cdc-Rel1A, cyclin E, synaptotagmin XI, SEPT5_v2 and PACRG (glup) (32,36,53,54,5661) (Fig.2). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]

Phrase: "approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449445:Approach [Spatial Concept]
  1000   C1292724:Approaches [Functional Concept]

Phrase: "many putative parkin substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710236:Substrate [Manufactured Object]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "synphilin-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "O-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "glycosylated -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(-Sp22"

Phrase: ")"

Phrase: ","

Phrase: "CHIP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600596:Chip [Research Device]

Phrase: "Pael-R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "cdc-Rel1A,"

Phrase: "cyclin E,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0111429:Cyclin E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1259807:Cyclin E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332697:CYCLIN E [Gene or Genome]

Phrase: "synaptotagmin XI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539651:synaptotagmin XI [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1426106:synaptotagmin XI [Gene or Genome]
   861   C1720296:Xi [Intellectual Product]

Phrase: "SEPT5_v2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0457423:V2 [Finding]
   861   C0507237:V2 [Body Part, Organ, or Organ Component]
   861   C1421140:V2 [Gene or Genome]

Phrase: "and"

Phrase: "PACRG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   728   C1418270:parkin gene [Gene or Genome]
   728   C2983548:Parkin Gene [Gene or Genome]

Phrase: "(glup"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1426045:Glup [Gene or Genome]

Phrase: ")"

Phrase: "(32,"

Phrase: "36,"

Phrase: "53,"

Phrase: "54,"

Phrase: "5661"

Phrase: ")"

Phrase: "(Fig.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.95: One may postulate parkin displays broad specificity and that many substrates accumulate in AR-JP brain with disastrous consequences for dopaminergic neurons. 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "may"

Phrase: "postulate"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "broad specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "that"

Phrase: "many substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]

Phrase: "accumulate in AR-JP brain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   853   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   804   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   778   C0441748:Autosomal recessive [Intellectual Product]
   778   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0242422:Parkinsonism [Disease or Syndrome]
   748   C0596142:autosomal [Cell Component]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C3146221:Juvenile [Age Group]

Phrase: "with disastrous consequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0686907:consequences [Functional Concept]

Phrase: "for dopaminergic neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1512035:Dopaminergic Neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.96: Indeed, accumulation of two substrates (-Sp22 and Pael-R) has been reported in parkin-proven AR-JP brain (32,56). 

Phrase: "Indeed,"

Phrase: "accumulation of two substrates"

Phrase: "(-Sp22"

Phrase: "and"

Phrase: "Pael-R)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "has"

Phrase: "been"

Phrase: "reported in parkin-proven AR-JP brain"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   818   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   784   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   764   C0441748:Autosomal recessive [Intellectual Product]
   764   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   742   C0006104:Brain [Body Part, Organ, or Organ Component]
   742   C0242422:Parkinsonism [Disease or Syndrome]
   742   C0456369:Proven [Qualitative Concept]
   742   C0596142:autosomal [Cell Component]
   742   C0684224:Reported [Intellectual Product]
   742   C0700287:Reported [Health Care Activity]
   742   C1269537:Brain [Body Part, Organ, or Organ Component]
   742   C1418270:PARKIN [Gene or Genome]
   742   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   742   C3146221:Juvenile [Age Group]
   742   C3496591:Reported [Clinical Attribute]
   708 E C3273238:Report [Intellectual Product]

Phrase: "(32,"

Phrase: "56"

Phrase: ")."
Processing 00000000.tx.97: However, an important caveat is that many putative substrates were identified utilizing in vitro techniques and remain to be validated. 

Phrase: "However,"

Phrase: "an important caveat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0871599:Caveat [Governmental or Regulatory Activity]

Phrase: "is"

Phrase: "that"

Phrase: "many putative substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "utilizing"

Phrase: "in vitro techniques"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025664:techniques [Intellectual Product]
   827   C0449851:Techniques [Functional Concept]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "validated."
Processing 00000000.tx.98: In vivo up-regulation in human brain tissue from parkin-proven disease, albeit end-stage, is an important consideration, although one might argue that the very neurons in which parkin's substrate(s) are likely to be up-regulated are the neurons most likely to have been lost and thus substrate accumulation would be difficult to detect. 

Phrase: "In vivo up-regulation in human brain tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "from parkin-proven disease,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "albeit"

Phrase: "end-stage,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0205088:End-stage [Temporal Concept]
       E   Terminal
   861   C0205390:Stage [Temporal Concept]
   861   C0444930:End [Spatial Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]
   861   C2746065:End [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]

Phrase: "is"

Phrase: "an important consideration,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0518609:consideration [Finding]

Phrase: "although"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "might"

Phrase: "argue"

Phrase: "that"

Phrase: "the very neurons in which parkin's substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0027882:Neurons [Cell]

Phrase: "("

Phrase: "s)"

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "up-regulated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulated [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]

Phrase: "are"

Phrase: "the neurons most likely to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0027882:Neurons [Cell]
   812   C0332148:Likely [Qualitative Concept]
   812   C0750492:Likely [Idea or Concept]
   741 E C0033204:Likelihood [Quantitative Concept]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "have"

Phrase: "been"

Phrase: "lost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]

Phrase: "and"

Phrase: "thus substrate accumulation"

Phrase: "would"

Phrase: "be"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "detect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]
Processing 00000000.tx.99: View larger version (27K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.100: Schematic diagram of parkin-mediated E3-ligase activity. 

Phrase: "Schematic diagram of parkin-mediated E3-ligase activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0681494:Diagram [Intellectual Product]
Processing 00000000.tx.101: Shown are identified E2 enzymes and substrates. 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "E2 enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.102: The methods used to identify the substrates are illustrated (see main text for specific references).   

Phrase: "The methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]

Phrase: "are"

Phrase: "illustrated"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "main text for specific references"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1527021:Text [Intellectual Product]
   760   C1554111:Text [Idea or Concept]
   760   C1705606:Text [Intellectual Product]
   760   C3541382:Text [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.103: MODELS OF PARKIN FUNCTION TOP ABSTRACT INTRODUCTION PARKIN-PROVEN PD: CLINICAL AND... 

Phrase: "MODELS OF PARKIN FUNCTION TOP ABSTRACT INTRODUCTION PARKIN-PROVEN PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C3161035:Models [Intellectual Product]

Phrase: ":"

Phrase: "CLINICAL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "AND..."
Processing 00000000.tx.104: PARKIN: MOLECULAR GENETICS PARKIN GENOMIC ORGANIZATION PARKIN, AN E3 UBIQUITIN... 

Phrase: "PARKIN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "MOLECULAR GENETICS PARKIN GENOMIC ORGANIZATION PARKIN,"

Phrase: "AN E3 UBIQUITIN..."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.105: MODELS OF PARKIN FUNCTION CONCLUSIONS REFERENCES  Cell and animal models provide a useful system to address the molecular basis of parkin dysfunction and dopaminergic cell loss. 

Phrase: "MODELS OF PARKIN FUNCTION CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Models [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "animal models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599779:Models, Animal [Animal]
   861   C0003062:Animal [Animal]
   861   C3161035:Models [Intellectual Product]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a useful system to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the molecular basis of parkin dysfunction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1853126:MOLECULAR BASIS [Idea or Concept]
   753   C1527178:Basis [Functional Concept]
   753   C1874451:Basis [Pharmacologic Substance]

Phrase: "and"

Phrase: "dopaminergic cell loss."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1517945:Loss [Quantitative Concept]
   734   C1512035:Dopaminergic cell [Cell]
Processing 00000000.tx.106: Hence, transgenic overexpression and knock-out models of PRKN have been generated to provide insight into wild-type parkin function and the mechanism of disease. 

Phrase: "Hence,"

Phrase: "transgenic overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514559:Overexpression [Genetic Function]

Phrase: "and"

Phrase: "knock-out"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0560617:knock out [Injury or Poisoning]
  1000   C1522225:Knock-out [Experimental Model of Disease]
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]

Phrase: "models of PRKN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1418270:parkin gene [Gene or Genome]
           PARKIN
   833   C2983548:Parkin Gene [Gene or Genome]
   770   C0017337:Gene [Gene or Genome]
   770   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C3161035:Model [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "insight into wild-type parkin function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0233820:Insight, function [Mental Process]
           Insight

Phrase: "and"

Phrase: "the mechanism of disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.107: Such models are critical at the present time, with the availability of human brain with parkin-proven disease being limited. 

Phrase: "Such models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "are"

Phrase: "critical at the present time,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511545:Critical [Qualitative Concept]

Phrase: "with the availability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Availability [Functional Concept]

Phrase: "of human brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "with parkin-proven disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "being"

Phrase: "limited."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.108: Overexpression of the wild-type parkin gene is postulated to play a protective role in the proteasomal degradation of damaged, misfolded or unwanted protein (62,63) and there is some evidence that PRKN expression is mediated by the unfolded protein response (64) although the finding is controversial (65). 

Phrase: "Overexpression of the wild-type parkin gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514559:Overexpression [Genetic Function]

Phrase: "is"

Phrase: "postulated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a protective role in the proteasomal degradation of damaged,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "misfolded"

Phrase: "or"

Phrase: "unwanted protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(62,"

Phrase: "63"

Phrase: ")"

Phrase: "and"

Phrase: "there"

Phrase: "is"

Phrase: "some evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that PRKN expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1418270:parkin gene [Gene or Genome]
   901   C2983548:Parkin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "mediated by the unfolded protein response"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1155342:Unfolded Protein Response [Molecular Function]
   783   C0870868:mediated response [Mental Process]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "(64"

Phrase: ")"

Phrase: "although"

Phrase: "the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "is"

Phrase: "controversial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0680243:controversies [Social Behavior]

Phrase: "(65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.109: The Drosophila PRKN null-model has a shorter life-span and compromised locomotor activity, compared to its wild-type counterpart, although the former is thought to be due to peripheral muscle neurodegeneration. 

Phrase: "The Drosophila PRKN null-model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3161035:Model [Intellectual Product]

Phrase: "has"

Phrase: "a shorter life-span"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0870809:life span [Group Attribute]
   827   C0376558:Life [Idea or Concept]
   827   C1711300:Span [Conceptual Entity]
   827   C2700613:Span [Quantitative Concept]
   743 E C0595998:lives [Finding]

Phrase: "and"

Phrase: "compromised locomotor activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0026606:Locomotor Activity [Daily or Recreational Activity]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "compared to its wild-type counterpart,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1707455:Compared [Activity]

Phrase: "although"

Phrase: "the former"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205156:Former [Temporal Concept]
  1000   C0750523:FORMER [Idea or Concept]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be due to peripheral muscle neurodegeneration."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0026845:Muscle [Tissue]
   753   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   753   C0205100:Peripheral [Spatial Concept]
   753   C2987476:Be [Conceptual Entity]
   753   C3146286:Due [Idea or Concept]
Processing 00000000.tx.110: As yet, in the central nervous system, there is little evidence for neuronal degeneration (66). 

Phrase: "As yet,"

Phrase: "in the central nervous system,"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "there"

Phrase: "is"

Phrase: "little evidence for neuronal degeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "(66"

Phrase: ")."
Processing 00000000.tx.111: There are presently three reports of PRKN null mice. 

Phrase: "There"

Phrase: "are"

Phrase: "presently three reports of PRKN null mice."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0684224:Reports [Intellectual Product]
   744   C0700287:reports [Health Care Activity]
   711 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.112: Two were created by ablation of exon 3 with consequent loss of parkin protein. 

Phrase: "Two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "were"

Phrase: "created by ablation of exon 3"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C1707531:Created By [Qualitative Concept]
   753   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0547070:Ablation [Therapeutic or Preventive Procedure]
   753   C1261381:ablation [Therapeutic or Preventive Procedure]
   753   C1706214:Created [Activity]
   719 E C3244320:create [Functional Concept]

Phrase: "with consequent loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517945:Loss [Quantitative Concept]

Phrase: "of parkin protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0673396:parkin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.113: Neither model demonstrates alteration in gross brain morphology or dopaminergic neuron loss. 

Phrase: "Neither model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "demonstrates"

Phrase: "alteration in gross brain morphology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1260954:Morphologic alteration [Anatomical Abnormality]
   760   C1515926:Alteration [Idea or Concept]

Phrase: "or"

Phrase: "dopaminergic neuron loss."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0598940:neuron loss [Finding]
   865 E C1850496:Neuronal loss [Finding]
   827   C1517945:Loss [Quantitative Concept]
   734   C1512035:Dopaminergic neuron [Cell]
Processing 00000000.tx.114: However, both models do exhibit nigrostriatal deficits, with subtle behavioral phenotypes which may represent a relatively early stage of the degenerative process (67,68). 

Phrase: "However,"

Phrase: "both models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "do"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "nigrostriatal deficits,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "with subtle behavioral phenotypes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1321146:behavioral phenotypes [Behavior]
   827   C0031437:Phenotypes [Organism Attribute]
   793 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "which"

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a relatively early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1279919:Early [Temporal Concept]

Phrase: "stage of the degenerative process"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0011164:Degenerative [Pathologic Function]
   760   C0205390:Stage [Temporal Concept]
   760   C1184743:Process [Body Part, Organ, or Organ Component]
   760   C1300072:Stage [Clinical Attribute]
   760   C1306673:Stage [Qualitative Concept]
   760   C1522240:Process [Phenomenon or Process]
   760   C1880269:Degenerative [Functional Concept]

Phrase: "(67,"

Phrase: "68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.115: The most recently described PRKN null model is the spontaneous mutant Quaking. 

Phrase: "The most recently described PRKN null model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C3161035:Model [Intellectual Product]

Phrase: "is"

Phrase: "the spontaneous mutant Quaking."
Processing 00000000.tx.116: First identified in 1964, homozygous mice are characterized by dysmyelination in the central nervous system and a quaking phenotype with tonic/clonic seizures in the adult. 

Phrase: "First"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "identified in 1964,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "homozygous mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "characterized by dysmyelination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1857639:Dysmyelination [Finding]
   790   C1880022:Characterized [Activity]

Phrase: "in the central nervous system"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "a quaking phenotype with tonic/clonic seizures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031437:Phenotype [Organism Attribute]
   748   C1285572:Phenotype [Laboratory Procedure]

Phrase: "in the adult."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001675:Adult [Age Group]
  1000   C1706450:Adult [Human]
Processing 00000000.tx.117: Analysis of quaking and ENU induced quaking alleles demonstrated mutation of the quaking gene (qkI) as the cause of the dysmyelinating phenotype (69,70). 

Phrase: "Analysis of quaking"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "ENU"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015111:ENU [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "quaking alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]

Phrase: "demonstrated"

Phrase: "mutation of the quaking gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0596611:Gene Mutation [Genetic Function]
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(qkI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1427319:QKI [Gene or Genome]

Phrase: ")"

Phrase: "as the cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "of the dysmyelinating phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "70"

Phrase: ")."
Processing 00000000.tx.118: The underlying genetic defect in quaking has now been defined as the deletion of a 1.17Mb region, encompassing the promoter of qkI and the PACRG/PRKN locus, with consequent loss of PACRG and parkin protein (71). 

Phrase: "The underlying genetic defect in quaking"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0000768:Birth Defect [Congenital Abnormality]
   762   C1737329:Birth defect [Congenital Abnormality]
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0314603:Genetic [Functional Concept]
   753   C1457869:Defect [Functional Concept]
   753   C1861101:DEFECT [Disease or Syndrome]

Phrase: "has"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "been"

Phrase: "defined as the deletion of a 1.17Mb region,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0017446:Region [Geographic Area]
   742   C0205147:Region [Spatial Concept]
   742   C1442161:Deletion [Cell or Molecular Dysfunction]
   742   C1511760:Deletion [Genetic Function]
   742   C1704788:Defined [Conceptual Entity]
   742   C1880274:Deletion [Activity]
   742   C3539106:Defined [Intellectual Product]

Phrase: "encompassing"

Phrase: "the promoter of qkI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the PACRG/PRKN locus,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   846   C1418270:parkin gene [Gene or Genome]
           PARKIN
   846   C2983548:Parkin Gene [Gene or Genome]
   824   C1708726:Gene Locus [Gene or Genome]
           Locus
   790   C0017337:Gene [Gene or Genome]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "with consequent loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517945:Loss [Quantitative Concept]

Phrase: "of PACRG"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   877   C1418270:parkin gene [Gene or Genome]
           PARKIN
   877   C2983548:Parkin Gene [Gene or Genome]
   795   C0017337:Gene [Gene or Genome]
   795   C0332285:Of [Spatial Concept]
   795   C0851285:Regulated [Governmental or Regulatory Activity]
   795   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "parkin protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0673396:parkin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.119: Similar to the transgenic models, alterations in dopamine metabolism and behavioral deficits have been noted, suggesting these animals might provide a model of parkin and PACRG function in neurodegeneration.t  CONCLUSIONS TOP ABSTRACT INTRODUCTION PARKIN-PROVEN PD: CLINICAL AND... 

Phrase: "Similar to the transgenic models,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "alterations in dopamine metabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "behavioral deficits"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "have"

Phrase: "been"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "these animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "might"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a model of parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "PACRG function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   710   C1418270:parkin gene [Gene or Genome]
   710   C2983548:Parkin Gene [Gene or Genome]

Phrase: "in neurodegeneration.t  CONCLUSIONS TOP ABSTRACT INTRODUCTION PARKIN-PROVEN PD"

Phrase: ":"

Phrase: "CLINICAL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "AND..."
Processing 00000000.tx.120: PARKIN: MOLECULAR GENETICS PARKIN GENOMIC ORGANIZATION PARKIN, AN E3 UBIQUITIN... 

Phrase: "PARKIN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "MOLECULAR GENETICS PARKIN GENOMIC ORGANIZATION PARKIN,"

Phrase: "AN E3 UBIQUITIN..."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.121: MODELS OF PARKIN FUNCTION CONCLUSIONS REFERENCES  The rapid pace of research in the PD field has been stimulated by the identification of causative mutations in the parkin and -synuclein genes in familial PD. 

Phrase: "MODELS OF PARKIN FUNCTION CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Models [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The rapid pace of research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0287990:PACE [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1552930:Pace [Quantitative Concept]

Phrase: "in the PD field"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   861   C1521738:Field [Conceptual Entity]
   861   C2346620:Field [Conceptual Entity]
   861   C2349184:Field [Conceptual Entity]
   861   C3539073:FIELD [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "stimulated by the identification of causative mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0020792:Identification [Mental Process]
   748   C0026882:Mutations [Genetic Function]
   748   C0205396:Identification [Qualitative Concept]
   748   C1948023:Stimulated [Natural Phenomenon or Process]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and -"

Phrase: "synuclein genes in familial PD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017337:Genes [Gene or Genome]
   745   C1517488:Gene Family [Gene or Genome]
Processing 00000000.tx.122: Alterations in the parkin gene clearly cause a disease that overlaps clinically and pathologically with idiopathic PD. 

Phrase: "Alterations in the parkin gene clearly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0596611:Gene Alteration [Genetic Function]
   719   C1515926:Alteration [Idea or Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "that"

Phrase: "overlaps"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185027:overlap [Therapeutic or Preventive Procedure]
  1000   C1948020:Overlap [Conceptual Entity]

Phrase: "clinically"

Phrase: "and"

Phrase: "pathologically with idiopathic PD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332240:Idiopathic [Functional Concept]
Processing 00000000.tx.123: To date, no single model organism recapitulates the features of AR-JP, nor does AR-JP represent all the aspects of PD, yet each is proving immensely valuable in dissecting the normal function and interactions of parkin in the dopaminergic system. 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "no single model organism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0029235:Organism [Organism]

Phrase: "recapitulates"

Phrase: "the features of AR-JP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   714   C1521970:Feature [Qualitative Concept]
   714   C1706388:Feature [Conceptual Entity]
   714   C2346469:Feature [Qualitative Concept]
   714   C2348519:Feature [Qualitative Concept]

Phrase: "nor"

Phrase: "does"

Phrase: "AR-JP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "all the aspects of PD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1547011:Aspect [Quantitative Concept]
   726   C1879746:Aspect [Qualitative Concept]

Phrase: "yet"

Phrase: "each"

Phrase: "is"

Phrase: "proving"

Phrase: "immensely valuable in dissecting"

Phrase: "the normal function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "interactions of parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1704675:Interaction [Functional Concept]

Phrase: "in the dopaminergic system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.124: Although PD represents a complex multifactorial syndrome, genetic research continues to provide novel hypotheses and the means to test them. 

Phrase: "Although"

Phrase: "PD"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a complex multifactorial syndrome,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039082:Syndrome [Disease or Syndrome]

Phrase: "genetic research"
Meta Candidates (Total=19; Excluded=14; Pruned=0; Remaining=5)
  1000   C0243064:Genetic Research [Research Activity]
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C0314603:Genetic [Functional Concept]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "continues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continue [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "novel hypotheses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: "and"

Phrase: "the means to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1704970:Means [Conceptual Entity]
   827 E C0444504:Mean [Quantitative Concept]
   827 E C2347634:Mean [Quantitative Concept]
   827 E C2348143:Mean [Quantitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "them."
Processing 00000000.tx.125: It is likely that there are many pathways to parkinsonism, nevertheless the genes/proteins identified, and the pathways highlighted, provide insight for future therapies.  

Phrase: "It"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that there"

Phrase: "are"

Phrase: "many pathways to parkinsonism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1704259:Pathways [Molecular Function]
   770   C1705987:Pathways [Conceptual Entity]

Phrase: "nevertheless"

Phrase: "the genes/proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0751455:genes proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "highlighted"

Phrase: ","

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "insight for future therapies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0679653:insight therapies [Therapeutic or Preventive Procedure]
   770   C0233820:Insight [Mental Process]
Processing 00000000.tx.126: FOOTNOTES  * To whom correspondence should be addressed at: Neurogenetics, Department of Neuroscience, Mayo Clinic Jacksonville, Birdsall Bldg, Rm 206, Jacksonville, FL 32224, USA. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed at"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0376649:Address [Intellectual Product]
   799   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Neurogenetics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597047:Neurogenetics [Biomedical Occupation or Discipline]

Phrase: "Department of Neuroscience,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "Mayo Clinic Jacksonville,"

Phrase: "Birdsall Bldg,"

Phrase: "Rm 206,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Jacksonville,"

Phrase: "FL 32224,"

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.127: Tel: +1 9049530158; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+1 9049530158"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.128: Fax: +1 9049537370; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+1 9049537370"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.129: Email: farrer.matthew{at}mayo.edu  REFERENCES TOP ABSTRACT INTRODUCTION PARKIN-PROVEN PD: CLINICAL AND... 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "farrer.matthew{at}mayo.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION PARKIN-PROVEN PD"

Phrase: ":"

Phrase: "CLINICAL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "AND..."
Processing 00000000.tx.130: PARKIN: MOLECULAR GENETICS PARKIN GENOMIC ORGANIZATION PARKIN, AN E3 UBIQUITIN... 

Phrase: "PARKIN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "MOLECULAR GENETICS PARKIN GENOMIC ORGANIZATION PARKIN,"

Phrase: "AN E3 UBIQUITIN..."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.131: MODELS OF PARKIN FUNCTION CONCLUSIONS REFERENCES  Lang, A.E. and Lozano, A.M. 

Phrase: "MODELS OF PARKIN FUNCTION CONCLUSIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Models [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Lang,"

Phrase: "A.E."

Phrase: "and"

Phrase: "Lozano,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.132: (1998) Parkinson's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.133: Second of two parts. 

Phrase: "Second of two parts."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205436:Second [Quantitative Concept]
   770   C0457385:Second [Temporal Concept]
   770   C0565930:/second [Quantitative Concept]
   770   C1561503:second [Idea or Concept]
   770   C1705190:Second [Qualitative Concept]
Processing 00000000.tx.134: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.135: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.136: J. 

Phrase: "J."
Processing 00000000.tx.137: Med., 339, 11301143.[Free FullText] Lang, A.E. and Lozano, A.M. 

Phrase: "Med.,"

Phrase: "339,"

Phrase: "11301143."

Phrase: "[Free FullText"

Phrase: "] Lang,"

Phrase: "A.E."

Phrase: "and"

Phrase: "Lozano,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.138: (1998) Parkinson's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.139: First of two parts. 

Phrase: "First of two parts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205435:First [Quantitative Concept]
   770   C1279901:First [Qualitative Concept]
Processing 00000000.tx.140: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.141: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.142: J. 

Phrase: "J."
Processing 00000000.tx.143: Med., 339, 10441053.[Free FullText] Fahn, S. 

Phrase: "Med.,"

Phrase: "339,"

Phrase: "10441053."

Phrase: "[Free FullText"

Phrase: "] Fahn,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1823105:FAHN [Gene or Genome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.144: (2003) Description of Parkinson's disease as a clinical syndrome. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Description of Parkinson's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C3259023:Disease description [Intellectual Product]
   770   C0678257:Description [Idea or Concept]

Phrase: "as a clinical syndrome."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221444:clinical syndrome [Classification]
   861   C0039082:Syndrome [Disease or Syndrome]
Processing 00000000.tx.145: Ann. 

Phrase: "Ann."
Processing 00000000.tx.146: N.Y. 

Phrase: "N.Y."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.147: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.148: Sci., 991, 114.[Abstract/Free FullText] Braak, H., Del Tredici, K., Rub, U., de Vos, R.A., Jansen Steur, E.N. and Braak, E. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "991,"

Phrase: "114."

Phrase: "[Abstract/Free FullText"

Phrase: "] Braak,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Del Tredici,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0445343:Tredici [Intellectual Product]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Rub,"

Phrase: "U.,"

Phrase: "de Vos,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "Jansen Steur,"

Phrase: "E.N."

Phrase: "and"

Phrase: "Braak,"

Phrase: "E."
Processing 00000000.tx.149: (2003) Staging of brain pathology related to sporadic Parkinson's disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Staging of brain pathology"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   783   C0443276:Pathological staging [Intellectual Product]
   783   C1320480:pathologic staging [Clinical Attribute]
   770   C0332305:Staging [Functional Concept]
   737 E C0205390:Stage [Temporal Concept]
   737 E C1300072:Stage [Clinical Attribute]
   737 E C1306673:Stage [Qualitative Concept]

Phrase: "related to sporadic Parkinson's disease."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C0030567:Parkinson Disease [Disease or Syndrome]
   806   C1521736:Parkinson's Disease [Functional Concept]
   806   C2681933:PARKINSON DISEASE [Gene or Genome]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0205422:Sporadic [Temporal Concept]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   726 E C0163712:Relate [Organic Chemical]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.150: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.151: Aging, 24, 197211.[CrossRef][Medline] Subramony, S.H., Hernandez, D., Adam, A., Smith-Jefferson, S., Hussey, J., Gwinn-Hardy, K., Lynch, T., McDaniel, O., Hardy, J., Farrer, M. et al. 

Phrase: "Aging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "24,"

Phrase: "197211."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Subramony,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hernandez,"

Phrase: "D."

Phrase: ","

Phrase: "Adam,"

Phrase: "A.,"

Phrase: "Smith-Jefferson,"

Phrase: "S."

Phrase: ","

Phrase: "Hussey,"

Phrase: "J.,"

Phrase: "Gwinn-Hardy,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lynch,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "McDaniel,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Farrer,"

Phrase: "M. et al."
Processing 00000000.tx.152: (2002) Ethnic differences in the expression of neurodegenerative disease: MachadoJoseph disease in Africans and Caucasians. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Ethnic differences in the expression of neurodegenerative disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0682076:ethnic differences [Finding]
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: ":"

Phrase: "MachadoJoseph disease in Africans"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Caucasians."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007457:Caucasians [Population Group]
  1000   C0043157:Caucasians [Population Group]
Processing 00000000.tx.153: Mov. 

Phrase: "Mov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825516:MOV [Quantitative Concept]
Processing 00000000.tx.154: Disord., 17, 10681071.[CrossRef][Medline] Payami, H., Nutt, J., Gancher, S., Bird, T., McNeal, M.G., Seltzer, W.K., Hussey, J., Lockhart, P., Gwinn-Hardy, K., Singleton, A.A. et al. 

Phrase: "Disord.,"

Phrase: "17,"

Phrase: "10681071."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Payami,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nutt,"

Phrase: "J.,"

Phrase: "Gancher,"

Phrase: "S."

Phrase: ","

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "McNeal,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Seltzer,"

Phrase: "W.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hussey,"

Phrase: "J.,"

Phrase: "Lockhart,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gwinn-Hardy,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A."

Phrase: "A. et al."
Processing 00000000.tx.155: (2003) SCA2 may present as levodopa-responsive parkinsonism. 

Phrase: "(2003"

Phrase: ")"

Phrase: "SCA2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0752121:SCA2 [Disease or Syndrome]
  1000   C1334353:SCA-2 [Gene or Genome]
  1000   C1705387:SCA-2 [Gene or Genome]

Phrase: "may"

Phrase: "present as levodopa-responsive parkinsonism."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0023570:Levodopa [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   760   C0150312:Present [Quantitative Concept]
   760   C0205342:Responsive [Functional Concept]
   760   C0242422:Parkinsonism [Disease or Syndrome]
   760   C0449450:Present [Idea or Concept]
   704 E C0699991:Larodopa [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   704 E C0720022:Dopar [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.156: Mov. 

Phrase: "Mov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825516:MOV [Quantitative Concept]
Processing 00000000.tx.157: Disord., 18, 425429.[CrossRef][Medline] Arawaka, S., Saito, Y., Murayama, S. and Mori, H. 

Phrase: "Disord.,"

Phrase: "18,"

Phrase: "425429."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Arawaka,"

Phrase: "S."

Phrase: ","

Phrase: "Saito,"

Phrase: "Y.,"

Phrase: "Murayama,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Mori,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.158: (1998) Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Lewy body in neurodegeneration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0085200:Lewy Body [Cell Component]
   770   C0242821:body [Human]
   770   C0460148:Body [Anatomical Structure]
   770   C1268086:Body [Anatomical Structure]

Phrase: "with brain iron accumulation type 1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0441729:Type 1 [Classification]
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   804   C0332307:Type [Qualitative Concept]
   804   C0376520:Iron [Inorganic Chemical]
   804   C1166521:iron [Pharmacologic Substance]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]
   804   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "immunoreactive for alpha-synuclein."
Processing 00000000.tx.159: Neurology, 51, 887889.[Abstract] McKeith, I.G., Burn, D.J., Ballard, C.G., Collerton, D., Jaros, E., Morris, C.M., McLaren, A., Perry, E.K., Perry, R., Piggott, M.A. et al. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "51,"

Phrase: "887889."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] McKeith,"

Phrase: "I.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Burn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006434:Burn [Injury or Poisoning]
  1000   C1550619:Burn [Substance]

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ballard,"

Phrase: "C.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Collerton,"

Phrase: "D."

Phrase: ","

Phrase: "Jaros,"

Phrase: "E.,"

Phrase: "Morris,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "McLaren,"

Phrase: "A.,"

Phrase: "Perry,"

Phrase: "E.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Perry,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Piggott,"

Phrase: "M.A. et al."
Processing 00000000.tx.160: (2003) Dementia with Lewy bodies. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Dementia with Lewy bodies."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.161: Semin. 

Phrase: "Semin."
Processing 00000000.tx.162: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.163: Neuropsychiatry, 8, 4657.[CrossRef][Medline] Jellinger, K.A. 

Phrase: "Neuropsychiatry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0870956:Neuropsychiatry [Biomedical Occupation or Discipline]

Phrase: "8,"

Phrase: "4657."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jellinger,"

Phrase: "K.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.164: (2003) Neuropathological spectrum of synucleinopathies. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Neuropathological spectrum of synucleinopathies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1883073:Spectrum [Quantitative Concept]
   770   C2827424:Spectrum [Conceptual Entity]
Processing 00000000.tx.165: Mov. 

Phrase: "Mov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825516:MOV [Quantitative Concept]
Processing 00000000.tx.166: Disord., 18, S212.[Medline] Dickson, D.W., Lin, W., Liu, W.K. and Yen, S.H. 

Phrase: "Disord.,"

Phrase: "18,"

Phrase: "S212."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dickson,"

Phrase: "D.W.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "W.,"

Phrase: "Liu,"

Phrase: "W.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Yen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555429:Yen [Quantitative Concept]

Phrase: "S."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.167: (1999) Multiple system atrophy: a sporadic synucleinopathy. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Multiple system atrophy"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]

Phrase: ":"

Phrase: "a sporadic synucleinopathy."
Processing 00000000.tx.168: Brain Pathol., 9, 721732.[Medline] Farrer, M., Gwinn-Hardy, K., Hutton, M. and Hardy, J. 

Phrase: "Brain Pathol.,"

Phrase: "9,"

Phrase: "721732."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Gwinn-Hardy,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Hardy,"

Phrase: "J."
Processing 00000000.tx.169: (1999) The genetics of disorders with synuclein pathology and parkinsonism. 

Phrase: "(1999"

Phrase: ")"

Phrase: "The genetics of disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017398:Genetics [Biomedical Occupation or Discipline]
   770   C0017399:genetics [Biologic Function]

Phrase: "with synuclein pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "parkinsonism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.170: Hum. 

Phrase: "Hum."
Processing 00000000.tx.171: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.172: Genet., 8, 19011905.[Abstract/Free FullText] Sherer, T.B., Betarbet, R. and Greenamyre, J.T. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "19011905."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sherer,"

Phrase: "T.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Betarbet,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Greenamyre,"

Phrase: "J.T."
Processing 00000000.tx.173: (2001) Pathogenesis of Parkinson's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Pathogenesis of Parkinson's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0543483:pathogenesis [Functional Concept]
   770   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.174: Curr. 

Phrase: "Curr."
Processing 00000000.tx.175: Opin. 

Phrase: "Opin."
Processing 00000000.tx.176: Investig. 

Phrase: "Investig."
Processing 00000000.tx.177: Drugs, 2, 657662.[Medline] Gwinn-Hardy, K. 

Phrase: "Drugs,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "657662."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gwinn-Hardy,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.178: (2002) Genetics of parkinsonism. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Genetics of parkinsonism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017398:Genetics [Biomedical Occupation or Discipline]
   790   C0017399:genetics [Biologic Function]
Processing 00000000.tx.179: Mov. 

Phrase: "Mov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825516:MOV [Quantitative Concept]
Processing 00000000.tx.180: Disord., 17, 645656.[CrossRef][Medline] Skipper, L. and Farrer, M. 

Phrase: "Disord.,"

Phrase: "17,"

Phrase: "645656."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Skipper,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Farrer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.181: (2002) Parkinson's genetics: molecular insights for the new millennium. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Parkinson's genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: ":"

Phrase: "molecular insights for the new millennium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0233820:insights [Mental Process]
Processing 00000000.tx.182: Neurotoxicology, 23, 503514.[CrossRef][Medline] Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. 

Phrase: "Neurotoxicology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597059:neurotoxicology [Organism Function]

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "503514."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Polymeropoulos,"

Phrase: "M."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein,"

Phrase: "J.,"

Phrase: "Boyer,"

Phrase: "R. et al."
Processing 00000000.tx.183: (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mutation in the alpha-synuclein gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0596611:Gene Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified in families"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0015576:Families [Family Group]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C1704727:Family [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "with Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.184: Science, 276, 20452047.[Abstract/Free FullText] Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J.T., Schols, L. and Riess, O. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "276,"

Phrase: "20452047."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kruger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kuhn,"

Phrase: "W.,"

Phrase: "Muller,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Woitalla,"

Phrase: "D."

Phrase: ","

Phrase: "Graeber,"

Phrase: "M."

Phrase: ","

Phrase: "Kosel,"

Phrase: "S."

Phrase: ","

Phrase: "Przuntek,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Epplen,"

Phrase: "J.T.,"

Phrase: "Schols,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Riess,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.185: (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Ala30Pro mutation in the gene encoding alpha-synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0596611:Gene Mutation [Genetic Function]
   744   C0026882:Mutation [Genetic Function]
   744   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.186: Nat. 

Phrase: "Nat."
Processing 00000000.tx.187: Genet., 18, 106108.[Medline] Zarranz, J.J., Alegre, J., Gmez-Esteban, J.C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atars, B. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "18,"

Phrase: "106108."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zarranz,"

Phrase: "J.J.,"

Phrase: "Alegre,"

Phrase: "J.,"

Phrase: "Gmez-Esteban,"

Phrase: "J.C., Lezcano,"

Phrase: "E.,"

Phrase: "Ros,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ampuero,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Vidal,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hoenicka,"

Phrase: "J.,"

Phrase: "Rodriguez,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Atars,"

Phrase: "B. et al."
Processing 00000000.tx.188: (2004) The new mutation, E46K, of alpha-synuclein causes parkinson and Lewy body dementia. 

Phrase: "(2004"

Phrase: ")"

Phrase: "The new mutation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2985439:new mutation [Cell or Molecular Dysfunction]
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "E46K,"

Phrase: "of alpha-synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "parkinson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   900   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "Lewy body dementia."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0752347:Dementia, Lewy Body [Disease or Syndrome]
  1000   C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   901   C0085200:Lewy Body [Cell Component]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.189: Ann. 

Phrase: "Ann."
Processing 00000000.tx.190: Neurol., 55, 164173.[CrossRef][Medline] Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R. et al. 

Phrase: "Neurol.,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "164173."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Johnson,"

Phrase: "J.,"

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.,"

Phrase: "Hague,"

Phrase: "S."

Phrase: ","

Phrase: "Kachergus,"

Phrase: "J.,"

Phrase: "Hulihan,"

Phrase: "M."

Phrase: ","

Phrase: "Peuralinna,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Nussbaum,"

Phrase: "R. et al."
Processing 00000000.tx.191: (2003) alpha-Synuclein locus triplication causes Parkinson's disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "alpha-Synuclein locus triplication"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.192: Science, 302, 841.[Free FullText] Farrer, M., Kachergus, J., Forno, L., Lincoln, S., Wang, D.-S., Hulihan, M., Maraganore, D., Gwinn-Hardy, K., Wszolek, Z., Dickson, D. and Langston, J.W. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "302,"

Phrase: "841."

Phrase: "[Free FullText"

Phrase: "] Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Kachergus,"

Phrase: "J.,"

Phrase: "Forno,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Wang,"

Phrase: "D.-S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Hulihan,"

Phrase: "M."

Phrase: ","

Phrase: "Maraganore,"

Phrase: "D."

Phrase: ","

Phrase: "Gwinn-Hardy,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wszolek,"

Phrase: "Z.,"

Phrase: "Dickson,"

Phrase: "D."

Phrase: "and"

Phrase: "Langston,"

Phrase: "J.W."
Processing 00000000.tx.193: (2004) Comparison of familial parkinsonism with dementia and -synuclein genomic multiplications. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Comparison of familial parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "with dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and -"

Phrase: "synuclein genomic multiplications."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2911648:Multiplication [Quantitative Concept]
Processing 00000000.tx.194: Ann. 

Phrase: "Ann."
Processing 00000000.tx.195: Neurol., 55, 174179.[CrossRef][Medline] Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan. 

Phrase: "Neurol.,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "174179."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chartier-Harlin,"

Phrase: "M.-C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kachergus,"

Phrase: "J.,"

Phrase: "Roumier,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Mouroux,"

Phrase: "V.,"

Phrase: "Douay,"

Phrase: "X.,"

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Levecque,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Larvor,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Andrieux,"

Phrase: "J.,"

Phrase: "Hulihan."
Processing 00000000.tx.196: M. et al. 

Phrase: "M. et al."
Processing 00000000.tx.197: (2004) -synuclein locus duplication causes familial Parkinson's disease. 

Phrase: "(2004"

Phrase: ") -"

Phrase: "synuclein locus duplication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332597:Duplication [Functional Concept]
   827   C1705960:Duplication [Cell or Molecular Dysfunction]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "familial Parkinson's disease."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0030567:Parkinson Disease [Disease or Syndrome]
   901   C1521736:Parkinson's Disease [Functional Concept]
   901   C2681933:PARKINSON DISEASE [Gene or Genome]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   727   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.198: Lancet Neurol., in press. 

Phrase: "Lancet Neurol.,"

Phrase: "in press."
Processing 00000000.tx.199: Farrer, M., Maraganore, D.M., Lockhart, P., Singleton, A., Lesnick, T.G., de Andrade, M., West, A., de Silva, R., Hardy, J. and Hernandez, D. 

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Maraganore,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Lockhart,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.,"

Phrase: "Lesnick,"

Phrase: "T.G.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]

Phrase: "de Andrade,"

Phrase: "M."

Phrase: ","

Phrase: "West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:West [Spatial Concept]

Phrase: "A.,"

Phrase: "de Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   789   C0144237:Silvan [Organic Chemical]
   768 E C0043217:Wood [Substance]
   768 E C0442548:Woods [Geographic Area]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hardy,"

Phrase: "J."

Phrase: "and"

Phrase: "Hernandez,"

Phrase: "D."
Processing 00000000.tx.200: (2001) alpha-Synuclein gene haplotypes are associated with Parkinson's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "alpha-Synuclein gene haplotypes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0018591:Haplotypes [Organism Attribute]
   756   C1420276:alpha synuclein gene [Gene or Genome]
   756   C2983377:Alpha-Synuclein Gene [Gene or Genome]
   708   C1537647:ALPHA GENE [Gene or Genome]
   708   C2985256:Alpha Gene [Gene or Genome]

Phrase: "are"

Phrase: "associated with Parkinson's disease."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.201: Hum. 

Phrase: "Hum."
Processing 00000000.tx.202: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.203: Genet., 10, 18471851.[Abstract/Free FullText] Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "10,"

Phrase: "18471851."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kitada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Matsumine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamamura,"

Phrase: "Y.,"

Phrase: "Minoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Yokochi,"

Phrase: "M."

Phrase: ","

Phrase: "Mizuno,"

Phrase: "Y."

Phrase: "and"

Phrase: "Shimizu,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.204: (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mutations in the parkin gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal recessive juvenile parkinsonism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.205: Nature, 392, 605608.[CrossRef][Medline] Saito, M., Maruyama, M., Ikeuchi, K., Kondo, H., Ishikawa, A., Yuasa, T. and Tsuji, S. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "392,"

Phrase: "605608."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Saito,"

Phrase: "M."

Phrase: ","

Phrase: "Maruyama,"

Phrase: "M."

Phrase: ","

Phrase: "Ikeuchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kondo,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ishikawa,"

Phrase: "A.,"

Phrase: "Yuasa,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Tsuji,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.206: (2000) Autosomal recessive juvenile parkinsonism. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Autosomal recessive juvenile parkinsonism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.207: Brain Dev., 22, S115S117.[CrossRef][Medline] Lohmann, E., Periquet, M., Bonifati, V., Wood, N.W., De Michele, G., Bonnet, A.M., Fraix, V., Broussolle, E., Horstink, M.W., Vidailhet, M. et al. 

Phrase: "Brain Dev.,"

Phrase: "22,"

Phrase: "S115S117."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lohmann,"

Phrase: "E.,"

Phrase: "Periquet,"

Phrase: "M."

Phrase: ","

Phrase: "Bonifati,"

Phrase: "V.,"

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "N.W., De Michele,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bonnet,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Fraix,"

Phrase: "V.,"

Phrase: "Broussolle,"

Phrase: "E.,"

Phrase: "Horstink,"

Phrase: "M."

Phrase: "W., Vidailhet,"

Phrase: "M. et al."
Processing 00000000.tx.208: (2003) How much phenotypic variation can be attributed to parkin genotype? 

Phrase: "(2003"

Phrase: ")"

Phrase: "How"

Phrase: "much phenotypic variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1836717:Phenotypic variation [Finding]
   861   C0205419:Variation [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "attributed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0449234:Attribute [Idea or Concept]
   966   C1704772:Attribute [Conceptual Entity]
   966   C1882133:Attribute [Qualitative Concept]

Phrase: "to parkin genotype?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]
Processing 00000000.tx.209: Ann. 

Phrase: "Ann."
Processing 00000000.tx.210: Neurol., 54, 176185.[CrossRef][Medline] Wu, R.M., Shan, D.E., Sun, C.M., Liu, R.S., Hwu, W.L., Tai, C.H., Hussey, J., West, A., Gwinn-Hardy, K., Hardy, J. et al. 

Phrase: "Neurol.,"

Phrase: "54,"

Phrase: "176185."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "M."

Phrase: ","

Phrase: "Shan,"

Phrase: "D."

Phrase: "E.,"

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Liu,"

Phrase: "R.S.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hwu,"

Phrase: "W.L., Tai,"

Phrase: "C.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Hussey,"

Phrase: "J.,"

Phrase: "West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:West [Spatial Concept]

Phrase: "A.,"

Phrase: "Gwinn-Hardy,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hardy,"

Phrase: "J. et al."
Processing 00000000.tx.211: (2002) Clinical, 18F-dopa PET, and genetic analysis of an ethnic Chinese kindred with early-onset parkinsonism and parkin gene mutations. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Clinical, 18F-dopa PET,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0031268:Pet [Animal]

Phrase: "and"

Phrase: "genetic analysis of an ethnic Chinese"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0679560:genetic analysis [Laboratory Procedure]
   790   C0796344:Genetic Analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "kindred with early-onset parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0598429:kindred [Qualitative Concept]

Phrase: "and"

Phrase: "parkin gene mutations."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0596611:gene mutations [Genetic Function]
   901   C1418270:parkin gene [Gene or Genome]
   901   C2983548:Parkin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.212: Mov. 

Phrase: "Mov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825516:MOV [Quantitative Concept]
Processing 00000000.tx.213: Disord., 17, 670675.[CrossRef][Medline] Rawal, N., Periquet, M., Lohmann, E., Lucking, C.B., Teive, H.A., Ambrosio, G., Raskin, S., Lincoln, S., Hattori, N., Guimaraes, J. et al. 

Phrase: "Disord.,"

Phrase: "17,"

Phrase: "670675."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rawal,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Periquet,"

Phrase: "M."

Phrase: ","

Phrase: "Lohmann,"

Phrase: "E.,"

Phrase: "Lucking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0870824:luck [Qualitative Concept]

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Teive,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "A.,"

Phrase: "Ambrosio,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Raskin,"

Phrase: "S."

Phrase: ","

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Guimaraes,"

Phrase: "J. et al."
Processing 00000000.tx.214: (2003) New parkin mutations and atypical phenotypes in families with autosomal recessive parkinsonism. 

Phrase: "(2003"

Phrase: ")"

Phrase: "New parkin mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   896   C2985439:new mutation [Cell or Molecular Dysfunction]
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "atypical phenotypes in families"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0031437:Phenotypes [Organism Attribute]
   737 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "with autosomal recessive parkinsonism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   827   C0242422:Parkinsonism [Disease or Syndrome]
   734   C0441748:Autosomal recessive [Intellectual Product]
Processing 00000000.tx.215: Neurology, 60, 13781381.[Abstract/Free FullText] Lincoln, S., Wiley, J., Lynch, T., Langston, J.W., Chen, R., Lang, A., Rogaeva, E., Sa, D.S., Munhoz, R.P., Harris, J. et al. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "60,"

Phrase: "13781381."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Wiley,"

Phrase: "J.,"

Phrase: "Lynch,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Langston,"

Phrase: "J.W., Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0999213:Chen [Bird]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lang,"

Phrase: "A.,"

Phrase: "Rogaeva,"

Phrase: "E.,"

Phrase: "Sa,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036243:SA [Geographic Area]
  1000   C1539696:SA [Gene or Genome]
  1000   C1825840:SA [Gene or Genome]
  1000   C3539736:Sa [Spatial Concept]

Phrase: "D.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Munhoz,"

Phrase: "R.P.,"

Phrase: "Harris,"

Phrase: "J. et al."
Processing 00000000.tx.216: (2003) Parkin-proven disease: Common founders but divergent phenotypes. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin-proven disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "Common founders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0263541:founders [Disease or Syndrome]

Phrase: "but"

Phrase: "divergent phenotypes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031437:Phenotypes [Organism Attribute]
   827 E C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.217: Neurology, 60, 16051610.[Abstract/Free FullText] Mori, H., Kondo, T., Yokochi, M., Matsumine, H., Nakagawa-Hattori, Y., Miyake, T., Suda, K. and Mizuno, Y. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "60,"

Phrase: "16051610."

Phrase: "[Abstract/Free FullText"

Phrase: "] Mori,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kondo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yokochi,"

Phrase: "M."

Phrase: ","

Phrase: "Matsumine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nakagawa-Hattori,"

Phrase: "Y.,"

Phrase: "Miyake,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Suda,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Mizuno,"

Phrase: "Y."
Processing 00000000.tx.218: (1998) Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q [see comments]. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Pathologic"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1521733:Pathologic [Functional Concept]
   928 E C0030664:Pathologies [Biomedical Occupation or Discipline]
   928 E C0205469:pathology [Functional Concept]
   928 E C0677042:pathology [Pathologic Function]

Phrase: "and"

Phrase: "biochemical studies of juvenile parkinsonism"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   797   C2699049:JUVENILE STUDIES [Regulation or Law]
   760   C0205474:Biochemical [Functional Concept]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "linked to chromosome 6q"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0008633:Chromosome [Cell Component]
   770   C1521554:6q [Nucleotide Sequence]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "["

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "comments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0282411:Comments [Intellectual Product]
  1000   C0947611:comments [Intellectual Product]
  1000   C1705247:Comments [Conceptual Entity]

Phrase: "]."
Processing 00000000.tx.219: Neurology, 51, 890892.[Abstract] Hayashi, S., Wakabayashi, K., Ishikawa, A., Nagai, H., Saito, M., Maruyama, M., Takahashi, T., Ozawa, T., Tsuji, S. and Takahashi, H. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "51,"

Phrase: "890892."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hayashi,"

Phrase: "S."

Phrase: ","

Phrase: "Wakabayashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ishikawa,"

Phrase: "A.,"

Phrase: "Nagai,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saito,"

Phrase: "M."

Phrase: ","

Phrase: "Maruyama,"

Phrase: "M."

Phrase: ","

Phrase: "Takahashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ozawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tsuji,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.220: (2000) An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene. 

Phrase: "(2000"

Phrase: ")"

Phrase: "An autopsy case of autosomal-recessive juvenile parkinsonism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004398:Autopsy [Diagnostic Procedure]
   744   C0868928:Case [Functional Concept]
   744   C1706255:CASE [Medical Device]
   744   C1706256:Case [Conceptual Entity]

Phrase: "with a homozygous exon 4 deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1442161:Deletion [Cell or Molecular Dysfunction]
   812   C1511760:Deletion [Genetic Function]
   812   C1880274:Deletion [Activity]

Phrase: "in the parkin gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.221: Mov. 

Phrase: "Mov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825516:MOV [Quantitative Concept]
Processing 00000000.tx.222: Disord., 15, 884888.[CrossRef][Medline] Matsumine, H. 

Phrase: "Disord.,"

Phrase: "15,"

Phrase: "884888."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Matsumine,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.223: (1998) A loss-of-function mechanism of nigral neuron death without Lewy body formation: autosomal recessive juvenile parkinsonism (AR-JP). 

Phrase: "(1998"

Phrase: ")"

Phrase: "A loss-of-function mechanism of nigral neuron death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441712:Mechanism [Functional Concept]
   742   C1706376:Mechanism [Manufactured Object]

Phrase: "without Lewy body formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0085200:Lewy Body [Cell Component]

Phrase: ":"

Phrase: "autosomal recessive juvenile parkinsonism (AR-JP)."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.224: J. 

Phrase: "J."
Processing 00000000.tx.225: Neurol., 245, P10P14.[Medline] Ishikawa, A. and Takahashi, H. 

Phrase: "Neurol.,"

Phrase: "245,"

Phrase: "P10P14."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ishikawa,"

Phrase: "A."

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.226: (1998) Clinical and neuropathological aspects of autosomal recessive juvenile parkinsonism. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "neuropathological aspects of autosomal recessive juvenile parkinsonism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1547011:Aspect [Quantitative Concept]
   714   C1879746:Aspect [Qualitative Concept]
Processing 00000000.tx.227: J. 

Phrase: "J."
Processing 00000000.tx.228: Neurol., 245, 49. 

Phrase: "Neurol.,"

Phrase: "245,"

Phrase: "49."
Processing 00000000.tx.229: Shimura, H., Schlossmacher, M.G., Hattori, N., Frosch, M.P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K.S. and Selkoe, D.J. 

Phrase: "Shimura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schlossmacher,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Frosch,"

Phrase: "M."

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Trockenbacher,"

Phrase: "A.,"

Phrase: "Schneider,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "Kosik,"

Phrase: "K.S."

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.230: (2001) Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Ubiquitination of a new form of alpha-synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1519751:Ubiquitination [Molecular Function]

Phrase: "by parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "from human brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "implications for Parkinson's disease."
Processing 00000000.tx.231: Science, 293, 263269.[Abstract/Free FullText] Farrer, M., Chan, P., Chen, R., Tan, L., Lincoln, S., Hernandez, D., Forno, L., Gwinn-Hardy, K., Petrucelli, L., Hussey, J. et al. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "293,"

Phrase: "263269."

Phrase: "[Abstract/Free FullText"

Phrase: "] Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Chan,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302595:tan [Individual Behavior]
  1000   C1537110:Tan [Clinical Attribute]
  1000   C3275241:Tan [Qualitative Concept]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Hernandez,"

Phrase: "D."

Phrase: ","

Phrase: "Forno,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Gwinn-Hardy,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Petrucelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hussey,"

Phrase: "J. et al."
Processing 00000000.tx.232: (2001) Lewy bodies and parkinsonism in families with parkin mutations. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "parkinsonism in families"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "with parkin mutations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.233: Ann. 

Phrase: "Ann."
Processing 00000000.tx.234: Neurol., 50, 293300.[CrossRef][Medline] van de Warrenburg, B.P., Lammens, M., Lucking, C.B., Denefle, P., Wesseling, P., Booij, J., Praamstra, P., Quinn, N., Brice, A. and Horstink, M.W. 

Phrase: "Neurol.,"

Phrase: "50,"

Phrase: "293300."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] van de Warrenburg,"

Phrase: "B.P.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Lammens,"

Phrase: "M."

Phrase: ","

Phrase: "Lucking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0870824:luck [Qualitative Concept]

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Denefle,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wesseling,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Booij,"

Phrase: "J.,"

Phrase: "Praamstra,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Quinn,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Brice,"

Phrase: "A."

Phrase: "and"

Phrase: "Horstink,"

Phrase: "M."

Phrase: "W."
Processing 00000000.tx.235: (2001) Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "pathologic abnormalities in a family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   726 E C1704258:Abnormality [Finding]

Phrase: "with parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "and"

Phrase: "parkin gene mutations."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0596611:gene mutations [Genetic Function]
   901   C1418270:parkin gene [Gene or Genome]
   901   C2983548:Parkin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.236: Neurology, 56, 555557.[Abstract/Free FullText] Morales, B., Martinez, A., Gonzalo, I., Vidal, L., Ros, R., Gomez-Tortosa, E., Rabano, A., Ampuero, I., Sanchez, M., Hoenicka, J. et al. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "56,"

Phrase: "555557."

Phrase: "[Abstract/Free FullText"

Phrase: "] Morales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026530:Morales [Individual Behavior]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Martinez,"

Phrase: "A.,"

Phrase: "Gonzalo,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Vidal,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Ros,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gomez-Tortosa,"

Phrase: "E.,"

Phrase: "Rabano,"

Phrase: "A.,"

Phrase: "Ampuero,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sanchez,"

Phrase: "M."

Phrase: ","

Phrase: "Hoenicka,"

Phrase: "J. et al."
Processing 00000000.tx.237: (2002) Steele-Richardson-Olszewski syndrome in a patient with a single C212Y mutation in the parkin protein. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Steele-Richardson-Olszewski syndrome in a patient"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0038868:Steele-Richardson-Olszewski Syndrome [Disease or Syndrome]
           Richardson's Syndrome
   748   C0039082:Syndrome [Disease or Syndrome]
   748   C0443048:Richardson [Intellectual Product]

Phrase: "with a single C212Y mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the parkin protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0673396:parkin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.238: Mov. 

Phrase: "Mov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825516:MOV [Quantitative Concept]
Processing 00000000.tx.239: Disord., 17, 13741380.[CrossRef][Medline] Chung, K.K., Zhang, Y., Lim, K.L., Tanaka, Y., Huang, H., Gao, J., Ross, C.A., Dawson, V.L. and Dawson, T.M. 

Phrase: "Disord.,"

Phrase: "17,"

Phrase: "13741380."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chung,"

Phrase: "K.K.,"

Phrase: "Zhang,"

Phrase: "Y.,"

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "K.L., Tanaka,"

Phrase: "Y.,"

Phrase: "Huang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gao,"

Phrase: "J.,"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."

Phrase: "A.,"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.240: (2001) Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "ubiquitinates"

Phrase: "the alpha-synuclein-interacting protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3541909:Alpha-Synuclein-Interacting Protein [Amino Acid, Peptide, or Protein]
   902   C1158819:alpha protein [Genetic Function]
   902   C2362546:Alpha protein [Amino Acid, Peptide, or Protein]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "implications for Lewy-body formation"

Phrase: "in Parkinson disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.241: Nat. 

Phrase: "Nat."
Processing 00000000.tx.242: Med., 7, 11441150.[CrossRef][Medline] Ardley, H.C., Scott, G.B., Rose, S.A., Tan, N.G., Markham, A.F. and Robinson, P.A. 

Phrase: "Med.,"

Phrase: "7,"

Phrase: "11441150."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ardley,"

Phrase: "H.C.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Scott,"

Phrase: "G.B.,"

Phrase: "Rose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035853:Rose [Plant]
  1000   C0995005:ROSE [Pharmacologic Substance]

Phrase: "S.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Tan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302595:tan [Individual Behavior]
  1000   C1537110:Tan [Clinical Attribute]
  1000   C3275241:Tan [Qualitative Concept]

Phrase: "N.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Markham,"

Phrase: "A.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Robinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443050:Robinson [Intellectual Product]

Phrase: "P.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.243: (2003) Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells over-expressing Parkin. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Inhibition of proteasomal activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "inclusion formation in neuronal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "non-neuronal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "over-expressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: "Parkin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.244: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.245: Biol. 

Phrase: "Biol."
Processing 00000000.tx.246: Cell, 14, 45414556.[Abstract/Free FullText] Cookson, M.R., Lockhart, P.J., McLendon, C., O'Farrell, C., Schlossmacher, M. and Farrer, M.J. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "14,"

Phrase: "45414556."

Phrase: "[Abstract/Free FullText"

Phrase: "] Cookson,"

Phrase: "M."

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lockhart,"

Phrase: "P.J.,"

Phrase: "McLendon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "O'Farrell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Schlossmacher,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Farrer,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.247: (2003) RING finger 1 mutations in Parkin produce altered localization of the protein. 

Phrase: "(2003"

Phrase: ")"

Phrase: "RING finger 1 mutations in Parkin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "produce"

Phrase: "altered localization of the protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0597704:protein localisation [Cell Function]
   797   C1159772:Protein Localization [Cell Function]
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]
Processing 00000000.tx.248: Hum. 

Phrase: "Hum."
Processing 00000000.tx.249: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.250: Genet., 12, 29572965.[Abstract/Free FullText] West, A., Farrer, M., Petrucelli, L., Cookson, M., Lockhart, P. and Hardy, J. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "29572965."

Phrase: "[Abstract/Free FullText"

Phrase: "] West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:West [Spatial Concept]

Phrase: "A.,"

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Petrucelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Cookson,"

Phrase: "M."

Phrase: ","

Phrase: "Lockhart,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Hardy,"

Phrase: "J."
Processing 00000000.tx.251: (2001) Identification and characterization of the human parkin gene promoter. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "characterization of the human parkin gene promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880022:Characterization [Activity]
Processing 00000000.tx.252: J. 

Phrase: "J."
Processing 00000000.tx.253: Neurochem., 78, 11461152.[CrossRef][Medline] Denison, S.R., Callahan, G., Becker, N.A., Phillips, L.A. and Smith, D.I. 

Phrase: "Neurochem.,"

Phrase: "78,"

Phrase: "11461152."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Denison,"

Phrase: "S.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Callahan,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Becker,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "A.,"

Phrase: "Phillips,"

Phrase: "L.A."

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "D."

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.254: (2003) Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Characterization of FRA6E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "its potential role in autosomal recessive juvenile parkinsonism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "ovarian cancer."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0029925:ovarian cancer [Neoplastic Process]
  1000   C1140680:Ovarian Cancer [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]
Processing 00000000.tx.255: Genes Chromosomes Cancer, 38, 4052.[CrossRef][Medline] Cesari, R., Martin, E.S., Calin, G.A., Pentimalli, F., Bichi, R., McAdams, H., Trapasso, F., Drusco, A., Shimizu, M., Masciullo, V. et al. 

Phrase: "Genes Chromosomes Cancer,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0919437:genes cancer [Gene or Genome]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]

Phrase: "38,"

Phrase: "4052."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cesari,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Martin,"

Phrase: "E.S.,"

Phrase: "Calin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108170:calin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A.,"

Phrase: "Pentimalli,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Bichi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "McAdams,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Trapasso,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Drusco,"

Phrase: "A.,"

Phrase: "Shimizu,"

Phrase: "M."

Phrase: ","

Phrase: "Masciullo,"

Phrase: "V. et al."
Processing 00000000.tx.256: (2003) Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "implicated in autosomal recessive juvenile parkinsonism,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   882   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   820   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   790   C0441748:Autosomal recessive [Intellectual Product]
   790   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   753   C0242422:Parkinsonism [Disease or Syndrome]
   753   C0596142:autosomal [Cell Component]
   753   C3146221:Juvenile [Age Group]

Phrase: "is"

Phrase: "a candidate tumor suppressor gene on chromosome 6q25-q27."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   818   C1707257:Candidate Tumor Suppressor Gene [Gene or Genome]
   790   C0079427:Tumor suppressor gene [Gene or Genome]
           Tumor Suppressor
   764   C0017372:Suppressor gene [Gene or Genome]
   764   C1325410:tumor suppressor [Cell Function]
   762   C0079429:A Gene [Gene or Genome]
   762   C1332838:Candidate Gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   742   C0027651:Tumor [Neoplastic Process]
   742   C1578706:Tumor [Intellectual Product]
   742   C1710252:Suppressor [Manufactured Object]
   742   C2954564:Suppressor [Pharmacologic Substance]
   742   C3273930:Tumor [Finding]
Processing 00000000.tx.257: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.258: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.259: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.260: USA, 100, 59565961.[Abstract/Free FullText] West, A.B. and Maidment, N.T. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "100,"

Phrase: "59565961."

Phrase: "[Abstract/Free FullText"

Phrase: "] West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:West [Spatial Concept]

Phrase: "A.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: "and"

Phrase: "Maidment,"

Phrase: "N.T."
Processing 00000000.tx.261: (2004) Genetics of parkin-linked disease. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Genetics of parkin-linked disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0019247:genetics disease [Disease or Syndrome]
   760   C0017398:Genetics [Biomedical Occupation or Discipline]
   760   C0017399:genetics [Biologic Function]
Processing 00000000.tx.262: Hum. 

Phrase: "Hum."
Processing 00000000.tx.263: Genet., in press. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "in press."
Processing 00000000.tx.264: Pankratz, N., Nichols, W.C., Uniacke, S.K., Halter, C., Murrell, J., Rudolph, A., Shults, C.W., Conneally, P.M., Foroud, T. and The Parkinson Study group (2003) Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families. 

Phrase: "Pankratz,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Nichols,"

Phrase: "W.C., Uniacke,"

Phrase: "S."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Halter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441229:Halter [Medical Device]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Murrell,"

Phrase: "J.,"

Phrase: "Rudolph,"

Phrase: "A.,"

Phrase: "Shults,"

Phrase: "C.W., Conneally,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Foroud,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "The Parkinson Study group"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0441833:Group [Idea or Concept]
   827   C0557651:Study [Manufactured Object]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C2603343:Study [Research Activity]

Phrase: "(2003"

Phrase: ")"

Phrase: "Genome-wide linkage analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0796345:linkage analysis [Laboratory Procedure]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0023745:linkage [Molecular Function]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "evidence of gene-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "by-gene interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0596610:gene interaction [Genetic Function]
   827   C1704675:Interaction [Functional Concept]

Phrase: "in a sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "of 362 multiplex Parkinson disease families."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0344339:disease family [Finding]
   804   C0015576:Families [Family Group]
   804   C1704727:Family [Conceptual Entity]
   721 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.265: Hum. 

Phrase: "Hum."
Processing 00000000.tx.266: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.267: Genet., 12, 25992608.[Abstract/Free FullText] West, A., Periquet, M., Lincoln, S., Lucking, C.B., Nicholl, D., Bonifati, V., Rawal, N., Gasser, T., Lohmann, E., Deleuze, J.F. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "25992608."

Phrase: "[Abstract/Free FullText"

Phrase: "] West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:West [Spatial Concept]

Phrase: "A.,"

Phrase: "Periquet,"

Phrase: "M."

Phrase: ","

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Lucking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0870824:luck [Qualitative Concept]

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Nicholl,"

Phrase: "D."

Phrase: ","

Phrase: "Bonifati,"

Phrase: "V.,"

Phrase: "Rawal,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Gasser,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Lohmann,"

Phrase: "E.,"

Phrase: "Deleuze,"

Phrase: "J.F. et al."
Processing 00000000.tx.268: (2002) Complex relationship between Parkin mutations and Parkinson disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Complex relationship between Parkin mutations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "Parkinson disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.269: Am. 

Phrase: "Am."
Processing 00000000.tx.270: J. 

Phrase: "J."
Processing 00000000.tx.271: Med. 

Phrase: "Med."
Processing 00000000.tx.272: Genet., 114, 584591.[CrossRef][Medline] Periquet, M., Lucking, C., Vaughan, J., Bonifati, V., Durr, A., De Michele, G., Horstink, M., Farrer, M., Illarioshkin, S.N., Pollak, P. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "114,"

Phrase: "584591."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Periquet,"

Phrase: "M."

Phrase: ","

Phrase: "Lucking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0870824:luck [Qualitative Concept]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Vaughan,"

Phrase: "J.,"

Phrase: "Bonifati,"

Phrase: "V.,"

Phrase: "Durr,"

Phrase: "A.,"

Phrase: "De Michele,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Horstink,"

Phrase: "M."

Phrase: ","

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Illarioshkin,"

Phrase: "S."

Phrase: "N., Pollak,"

Phrase: "P. et al."
Processing 00000000.tx.273: (2001) Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Origin of the mutations"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   791   C0026882:genetic mutations [Genetic Function]
   770   C0079946:origin [Classification]
   770   C0439659:Origin [Temporal Concept]
   770   C1550512:origin [Intellectual Product]
   715 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   715 E C0314603:Genetic [Functional Concept]

Phrase: "in the parkin gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "in Europe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015176:Europe [Geographic Area]

Phrase: ":"

Phrase: "exon rearrangements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511695:Rearrangements [Genetic Function]

Phrase: "are"

Phrase: "independent recurrent events,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]

Phrase: "whereas"

Phrase: "point mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "result from Founder effects."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0242918:Founder Effects [Phenomenon or Process]
   770   C0263541:Founder [Disease or Syndrome]
   770   C1274040:Result [Functional Concept]
   770   C1280500:effects [Qualitative Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]
   737 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.274: Am. 

Phrase: "Am."
Processing 00000000.tx.275: J. 

Phrase: "J."
Processing 00000000.tx.276: Hum. 

Phrase: "Hum."
Processing 00000000.tx.277: Genet., 68, 617626.[CrossRef][Medline] Hedrich, K., Kann, M., Lanthaler, A.J., Dalski, A., Eskelson, C., Landt, O., Schwinger, E., Vieregge, P., Lang, A.E., Breakefield, X.O. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "617626."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hedrich,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kann,"

Phrase: "M."

Phrase: ","

Phrase: "Lanthaler,"

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "Dalski,"

Phrase: "A.,"

Phrase: "Eskelson,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Landt,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Schwinger,"

Phrase: "E.,"

Phrase: "Vieregge,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lang,"

Phrase: "A.E.,"

Phrase: "Breakefield,"

Phrase: "X.O. et al."
Processing 00000000.tx.278: (2001) The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. 

Phrase: "(2001"

Phrase: ")"

Phrase: "The importance of gene dosage studies"

Phrase: ":"

Phrase: "mutational analysis of the parkin gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1294200:Gene mutation analysis [Laboratory Procedure]
   754   C0796357:mutation analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "in early-onset parkinsonism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1838631:Parkinsonism, early-onset [Finding]
   827   C0242422:Parkinsonism [Disease or Syndrome]
   734   C1833334:Early-onset [Finding]
Processing 00000000.tx.279: Hum. 

Phrase: "Hum."
Processing 00000000.tx.280: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.281: Genet., 10, 16491656.[Abstract/Free FullText] Lcking, C., Drr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B.S., Meco, G., Denefle, P., Wood, N.W. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "10,"

Phrase: "16491656."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lcking,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Drr,"

Phrase: "A.,"

Phrase: "Bonifati,"

Phrase: "V.,"

Phrase: "Vaughan,"

Phrase: "J.,"

Phrase: "De Michele,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Gasser,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Harhangi,"

Phrase: "B.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Meco,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Denefle,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "N.W. et al."
Processing 00000000.tx.282: (2000) Association between early-onset Parkinson's disease and mutations in the parkin gene. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Association between early-onset Parkinson's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1511978:Disease Association [Temporal Concept]
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "mutations in the parkin gene."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.283: French Parkinson's Disease Genetics Study Group. 

Phrase: "French Parkinson's Disease Genetics Study Group."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   799   C0441833:Group [Idea or Concept]
   799   C0557651:Study [Manufactured Object]
   799   C0687744:group [Population Group]
   799   C1257890:Group [Population Group]
   799   C1552516:Group [Health Care Related Organization]
   799   C1705428:Group [Conceptual Entity]
   799   C1705429:Group [Population Group]
   799   C2603343:Study [Research Activity]
Processing 00000000.tx.284: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.285: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.286: J. 

Phrase: "J."
Processing 00000000.tx.287: Med., 342, 15601567.[Abstract/Free FullText] Lincoln, S.J., Maraganore, D.M., Lesnick, T.G., Bounds, R., de Andrade, M., Bower, J.H., Hardy, J.A. and Farrer, M.J. 

Phrase: "Med.,"

Phrase: "342,"

Phrase: "15601567."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lincoln,"

Phrase: "S."

Phrase: "J.,"

Phrase: "Maraganore,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Lesnick,"

Phrase: "T.G.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603360:T' [Clinical Attribute]

Phrase: "Bounds,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0332297:bounds [Spatial Concept]
   966 E C1145667:Bound [Activity]
   966 E C1167622:Bound [Molecular Function]
   966 E C1689898:% bound [Quantitative Concept]
   966 E C2349209:Bound [Conceptual Entity]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "de Andrade,"

Phrase: "M."

Phrase: ","

Phrase: "Bower,"

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hardy,"

Phrase: "J."

Phrase: "A."

Phrase: "and"

Phrase: "Farrer,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.288: (2003) Parkin variants in North American Parkinson's disease: cases and controls. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin variants in North American Parkinson's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:variants [Qualitative Concept]

Phrase: ":"

Phrase: "cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.289: Mov. 

Phrase: "Mov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825516:MOV [Quantitative Concept]
Processing 00000000.tx.290: Disord., 18, 13061311.[CrossRef][Medline] Asakawa, S., Tsunematsu, K., Takayanagi, A., Sasaki, T., Shimizu, A., Shintani, A., Kawasaki, K., Mungall, A.J., Beck, S., Minoshima, S. et al. 

Phrase: "Disord.,"

Phrase: "18,"

Phrase: "13061311."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Tsunematsu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takayanagi,"

Phrase: "A.,"

Phrase: "Sasaki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Shimizu,"

Phrase: "A.,"

Phrase: "Shintani,"

Phrase: "A.,"

Phrase: "Kawasaki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Mungall,"

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "Beck,"

Phrase: "S."

Phrase: ","

Phrase: "Minoshima,"

Phrase: "S. et al."
Processing 00000000.tx.291: (2001) The genomic structure and promoter region of the human parkin gene. 

Phrase: "(2001"

Phrase: ")"

Phrase: "The genomic structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "promoter region of the human parkin gene."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   774   C0314621:Promoter gene [Gene or Genome]
   748   C0017446:Region [Geographic Area]
   748   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205147:Region [Spatial Concept]
Processing 00000000.tx.292: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.293: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.294: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.295: Commun., 286, 863868.[CrossRef][Medline] West, A., Lockhart, P., O'Farrell, C. and Farrer, M. 

Phrase: "Commun.,"

Phrase: "286,"

Phrase: "863868."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:West [Spatial Concept]

Phrase: "A.,"

Phrase: "Lockhart,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "O'Farrell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "C."

Phrase: "and"

Phrase: "Farrer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.296: (2003) Identification of a novel gene linked to parkin via a bi-directional promoter. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Identification of a novel gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "to parkin via a bi-directional promoter."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1418270:PARKIN [Gene or Genome]
   748   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.297: J. 

Phrase: "J."
Processing 00000000.tx.298: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.299: Biol., 326, 1119.[CrossRef][Medline] West, A.B., Kapatos, G., O'Farrell, C., Gonzalez-de-Chavez, F., Chiu, K., Farrer, M. and Maidment, N.T. 

Phrase: "Biol.,"

Phrase: "326,"

Phrase: "1119."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:West [Spatial Concept]

Phrase: "A.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: "Kapatos,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "O'Farrell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Gonzalez-de-Chavez,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Chiu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Farrer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Maidment,"

Phrase: "N.T."
Processing 00000000.tx.300: (2004) N-myc regulates parkin expression. 

Phrase: "(2004"

Phrase: ")"

Phrase: "N-myc"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0812287:N-myc [Gene or Genome]
  1000   C1705027:N-myc [Gene or Genome]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "regulates"

Phrase: "parkin expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.301: J. 

Phrase: "J."
Processing 00000000.tx.302: Neurosci., in press. 

Phrase: "Neurosci.,"

Phrase: "in press."
Processing 00000000.tx.303: Galderisi, U., Jori, F.P. and Giordano, A. 

Phrase: "Galderisi,"

Phrase: "U.,"

Phrase: "Jori,"

Phrase: "F.P."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Giordano,"

Phrase: "A."
Processing 00000000.tx.304: (2003) Cell cycle regulation and neural differentiation. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Cell cycle regulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1155872:Cell Cycle Regulation [Cell Function]
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]

Phrase: "and"

Phrase: "neural differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.305: Oncogene, 22, 52085219.[CrossRef][Medline] Imai, Y., Soda, M., Murakami, T., Shoji, M., Abe, K. and Takahashi, R. 

Phrase: "Oncogene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]

Phrase: "22,"

Phrase: "52085219."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Imai,"

Phrase: "Y.,"

Phrase: "Soda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683086:soda [Food]

Phrase: "M."

Phrase: ","

Phrase: "Murakami,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Shoji,"

Phrase: "M."

Phrase: ","

Phrase: "Abe,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0155685:abe [Disease or Syndrome]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.306: (2003) A product of the human gene adjacent to parkin is a component of Lewy bodies and suppresses pael receptor-induced cell death. 

Phrase: "(2003"

Phrase: ")"

Phrase: "A product of the human gene adjacent to parkin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C1514468:product [Entity]
   742   C1704444:Product [Quantitative Concept]

Phrase: "is"

Phrase: "a component of Lewy bodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "pael receptor-induced cell death."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   853   C1514760:Receptor Cell [Cell]
   840   C0007587:Cell Death [Cell Function]
   804   C0007634:Cell [Cell]
   804   C0011065:Death [Organism Function]
   804   C1269647:Cell [Cell]
   804   C1306577:Death, NOS [Finding]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.307: J. 

Phrase: "J."
Processing 00000000.tx.308: Biol. 

Phrase: "Biol."
Processing 00000000.tx.309: Chem., 278, 5190151910.[Abstract/Free FullText] Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimuzu, N., Iwai, K., Chiba, T., Tanaka, K. et al. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "5190151910."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shimura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kubo,"

Phrase: "S."

Phrase: ","

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Minoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Shimuzu,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Iwai,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Chiba,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tanaka,"

Phrase: "K. et al."
Processing 00000000.tx.310: (2000) Familial parkinson disease gene product, parkin, is a ubiquitin-protein ligase. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Familial parkinson disease gene product,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1416989:MAL gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]

Phrase: "parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a ubiquitin-protein ligase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0077678:ubiquitin-protein ligase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1256818:Ubiquitin Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1307637:Ubiquitin-Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1442769:ubiquitin-protein ligase [Gene or Genome]
   827   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.311: Nat. 

Phrase: "Nat."
Processing 00000000.tx.312: Genet., 25, 302305.[CrossRef][Medline] Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y. and Takahashi, R. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "25,"

Phrase: "302305."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Imai,"

Phrase: "Y.,"

Phrase: "Soda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683086:soda [Food]

Phrase: "M."

Phrase: ","

Phrase: "Inoue,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mizuno,"

Phrase: "Y."

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.313: (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. 

Phrase: "(2001"

Phrase: ")"

Phrase: "An unfolded putative transmembrane polypeptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "can"

Phrase: "lead to endoplasmic reticulum stress,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0038435:Stress [Finding]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "a substrate of Parkin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.314: Cell, 105, 891902.[CrossRef][Medline] Choi, P., Snyder, H., Petrucelli, L., Theisler, C., Chong, M., Zhang, Y., Lim, K., Chung, K.K., Kehoe, K., D'Adamio, L. et al. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "105,"

Phrase: "891902."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Choi,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Snyder,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Petrucelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Theisler,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Chong,"

Phrase: "M."

Phrase: ","

Phrase: "Zhang,"

Phrase: "Y.,"

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Chung,"

Phrase: "K.K.,"

Phrase: "Kehoe,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "D'"

Phrase: "Adamio,"

Phrase: "L. et al."
Processing 00000000.tx.315: (2003) SEPT5_v2 is a parkin-binding protein. 

Phrase: "(2003"

Phrase: ")"

Phrase: "SEPT5_v2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0457423:V2 [Finding]
   861   C0507237:V2 [Body Part, Organ, or Organ Component]
   861   C1421140:V2 [Gene or Genome]

Phrase: "is"

Phrase: "a parkin-binding protein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0673396:parkin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
Processing 00000000.tx.316: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.317: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.318: Brain. 

Phrase: "Brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.319: Res., 117, 179189.[Medline] Corti, O., Hampe, C., Koutnikova, H., Darios, F., Jacquier, S., Prigent, A., Robinson, J.C., Pradier, L., Ruberg, M., Mirande, M. et al. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "117,"

Phrase: "179189."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Corti,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Hampe,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Koutnikova,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Darios,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Jacquier,"

Phrase: "S."

Phrase: ","

Phrase: "Prigent,"

Phrase: "A.,"

Phrase: "Robinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443050:Robinson [Intellectual Product]

Phrase: "J.C., Pradier,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Ruberg,"

Phrase: "M."

Phrase: ","

Phrase: "Mirande,"

Phrase: "M. et al."
Processing 00000000.tx.320: (2003) The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. 

Phrase: "(2003"

Phrase: ")"

Phrase: "The p38 subunit of the aminoacyl-tRNA synthetase complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1711351:Subunit [Quantitative Concept]

Phrase: "is"

Phrase: "a Parkin substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: ":"

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "protein biosynthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0597295:Protein Biosynthesis [Molecular Function]
   861   C0005572:biosynthesis [Functional Concept]
   861   C0220781:Biosynthesis [Biologic Function]

Phrase: "and"

Phrase: "neurodegeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.321: Hum. 

Phrase: "Hum."
Processing 00000000.tx.322: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.323: Genet., 12, 14271437.[Abstract/Free FullText] Zhang, Y., Gao, J., Chung, K.K., Huang, H., Dawson, V.L. and Dawson, T.M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "14271437."

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhang,"

Phrase: "Y.,"

Phrase: "Gao,"

Phrase: "J.,"

Phrase: "Chung,"

Phrase: "K.K.,"

Phrase: "Huang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.324: (2000) Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "functions as an E2-dependent ubiquitin- protein ligase"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   800   C0077678:ubiquitin-protein ligase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1256818:Ubiquitin Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1307637:Ubiquitin-Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1442769:ubiquitin-protein ligase [Gene or Genome]
   767   C0815043:function protein [Amino Acid, Peptide, or Protein]
   767   C1527118:Protein Function [Molecular Function]
   744   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031843:function [Physiologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C1705273:Function [Intellectual Product]
   744   C3244310:dependent [Functional Concept]
   744   C3539520:E2 [Gene or Genome]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the degradation of the synaptic vesicle-associated protein,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0597297:Protein Degradation [Molecular Function]
   767   C0597304:Protein Degradation [Molecular Function]
   767   C1623036:Protein Degradation [Molecular Function]
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]

Phrase: "CDCrel-1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
  1000   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   861   C1539748:CDCREL [Gene or Genome]
Processing 00000000.tx.325: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.326: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.327: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.328: USA, 97, 1335413359.[Abstract/Free FullText] Huynh, D.P., Scoles, D.R., Nguyen, D. and Pulst, S.M. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "1335413359."

Phrase: "[Abstract/Free FullText"

Phrase: "] Huynh,"

Phrase: "D.P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512024:D.P. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Scoles,"

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Nguyen,"

Phrase: "D."

Phrase: "and"

Phrase: "Pulst,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.329: (2003) The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. 

Phrase: "(2003"

Phrase: ")"

Phrase: "The autosomal recessive juvenile Parkinson disease gene product,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0017361:Recessive gene [Gene or Genome]
   818   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0017337:Gene [Gene or Genome]
   795   C1514468:product [Entity]
   795   C1704444:Product [Quantitative Concept]
   790   C1416989:MAL gene [Gene or Genome]
   747   C1868675:Autosomal Recessive Juvenile Parkinson Disease [Disease or Syndrome]

Phrase: "parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts with"

Phrase: "and"

Phrase: "ubiquitinates"

Phrase: "synaptotagmin XI."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539651:synaptotagmin XI [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1426106:synaptotagmin XI [Gene or Genome]
   861   C1720296:Xi [Intellectual Product]
Processing 00000000.tx.330: Hum. 

Phrase: "Hum."
Processing 00000000.tx.331: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.332: Genet., 12, 25872597.[Abstract/Free FullText] Staropoli, J.F., McDermott, C., Martinat, C., Schulman, B., Demireva, E. and Abeliovich, A. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "25872597."

Phrase: "[Abstract/Free FullText"

Phrase: "] Staropoli,"

Phrase: "J.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "McDermott,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Martinat,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Schulman,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Demireva,"

Phrase: "E."

Phrase: "and"

Phrase: "Abeliovich,"

Phrase: "A."
Processing 00000000.tx.333: (2003) Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a component of an SCF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]

Phrase: "like ubiquitin ligase complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1167313:ubiquitin ligase complex [Cell Component]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "protects"

Phrase: "postmitotic neurons from kainate excitotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027882:Neurons [Cell]
Processing 00000000.tx.334: Neuron, 37, 735749.[Medline] Cookson, M.R. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "37,"

Phrase: "735749."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cookson,"

Phrase: "M."

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.335: (2003) Parkin's substrates and the pathways leading to neuronal damage. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin's substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "the pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "leading to neuronal damage."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0010957:Damage [Injury or Poisoning]
   770   C0332152:Leading [Temporal Concept]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1522538:Leading [Functional Concept]
   770   C1883709:Damage [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.336: Neuromolecular Med., 3, 113.[CrossRef][Medline] Petrucelli, L., O'Farrell, C., Lockhart, P.J., Baptista, M., Kehoe, K., Vink, L., Choi, P., Wolozin, B., Farrer, M., Hardy, J. et al. 

Phrase: "Neuromolecular Med.,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "113."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Petrucelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "O'Farrell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lockhart,"

Phrase: "P.J.,"

Phrase: "Baptista,"

Phrase: "M."

Phrase: ","

Phrase: "Kehoe,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vink,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Choi,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wolozin,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J. et al."
Processing 00000000.tx.337: (2002) Parkin protects against the toxicity associated with mutant alpha-synuclein. proteasome dysfunction selectively affects catecholaminergic neurons. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "protects against the toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]

Phrase: "associated with mutant alpha-synuclein. proteasome dysfunction selectively"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   770   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   744   C0031847:dysfunction [Functional Concept]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0277785:Dysfunction, NOS [Qualitative Concept]
   744   C0439095:Alpha [Intellectual Product]
   744   C0596988:Mutant [Cell or Molecular Dysfunction]
   744   C1325620:proteasome [Cell Component]
   744   C1752727:Proteasome [Molecular Function]
   744   C2003941:Alpha [Intellectual Product]
   744   C2350010:Alpha [Qualitative Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "catecholaminergic neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.338: Neuron, 36, 10071019.[Medline] Tsai, Y.C., Fishman, P.S., Thakor, N.V. and Oyler, G.A. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "36,"

Phrase: "10071019."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tsai,"

Phrase: "Y.C., Fishman,"

Phrase: "P.S.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0234833:P s [Organ or Tissue Function]
  1000   C0722388:P & S [Organic Chemical,Pharmacologic Substance]

Phrase: "Thakor,"

Phrase: "N.V."

Phrase: "and"

Phrase: "Oyler,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.339: (2003) Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "facilitates"

Phrase: "the elimination of expanded polyglutamine proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0221102:Elimination [Physiologic Function]

Phrase: "and"

Phrase: "leads to preservation of proteasome function."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   783   C3640044:Lead Function [Conceptual Entity]
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0031843:function [Physiologic Function]
   753   C0033085:Preservation [Laboratory Procedure]
   753   C0181586:leads [Medical Device]
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1325620:proteasome [Cell Component]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1514402:Preservation [Laboratory Procedure]
   753   C1522538:Lead [Functional Concept]
   753   C1705273:Function [Intellectual Product]
   753   C1752727:Proteasome [Molecular Function]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.340: J. 

Phrase: "J."
Processing 00000000.tx.341: Biol. 

Phrase: "Biol."
Processing 00000000.tx.342: Chem., 278, 2204422055.[Abstract/Free FullText] Imai, Y., Soda, M., Takahashi, R., Hattori, N., Mizuno, Y., Zhang, Y., Gao, J., Chung, K.K., Huang, H., Dawson, V.L. et al. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "2204422055."

Phrase: "[Abstract/Free FullText"

Phrase: "] Imai,"

Phrase: "Y.,"

Phrase: "Soda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683086:soda [Food]

Phrase: "M."

Phrase: ","

Phrase: "Takahashi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "Zhang,"

Phrase: "Y.,"

Phrase: "Gao,"

Phrase: "J.,"

Phrase: "Chung,"

Phrase: "K.K.,"

Phrase: "Huang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L. et al."
Processing 00000000.tx.343: (2000) Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "unfolded protein stress-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007587:Cell Death [Cell Function]
   799   C0007634:Cell [Cell]
   799   C0011065:Death [Organism Function]
   799   C1269647:Cell [Cell]
   799   C1306577:Death, NOS [Finding]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]

Phrase: "through its E3 ubiquitin-protein ligase activity."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   937   C1150685:ubiquitin-protein ligase activity [Molecular Function]
           ubiquitin-ligase activity
   875   C1325411:ubiquitin activity [Molecular Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1150651:ligase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   722   C0077678:E3 Ubiquitin Ligase [Amino Acid, Peptide, or Protein,Enzyme]
           ubiquitin-protein ligase
           E3 Ligase
   722   C1418270:E3 ubiquitin ligase [Gene or Genome]
   717   C1256818:Ubiquitin Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1307637:Ubiquitin-Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1442769:ubiquitin-protein ligase [Gene or Genome]
Processing 00000000.tx.344: J. 

Phrase: "J."
Processing 00000000.tx.345: Biol. 

Phrase: "Biol."
Processing 00000000.tx.346: Chem., 275, 3566135664.[Abstract/Free FullText] West, A.B., Gonzalez-de-Chavez, F., Wilkes, K., O'Farrell, C. and Farrer, M.J. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "275,"

Phrase: "3566135664."

Phrase: "[Abstract/Free FullText"

Phrase: "] West,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:West [Spatial Concept]

Phrase: "A.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: "Gonzalez-de-Chavez,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Wilkes,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "O'Farrell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "C."

Phrase: "and"

Phrase: "Farrer,"

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.347: (2003) Parkin is not regulated by the unfolded protein response in human neuroblastoma cells. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "regulated by the unfolded protein response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1155342:Unfolded Protein Response [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "in human neuroblastoma cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0427861:Human cells [Laboratory or Test Result]
   884   C0815000:neuroblastoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.348: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.349: Lett., 341, 139142.[CrossRef][Medline] Greene, J.C., Whitworth, A.J., Kuo, I., Andrews, L.A., Feany, M.B. and Pallanck, L.J. 

Phrase: "Lett.,"

Phrase: "341,"

Phrase: "139142."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Greene,"

Phrase: "J.C., Whitworth,"

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "Kuo,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Andrews,"

Phrase: "L.A.,"

Phrase: "Feany,"

Phrase: "M.B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Pallanck,"

Phrase: "L.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.350: (2003) Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Mitochondrial pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "apoptotic muscle degeneration in Drosophila parkin mutants."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0234958:MUSCLE DEGENERATION [Disease or Syndrome]
   748   C0011164:Degeneration [Pathologic Function]
   748   C1880269:Degeneration [Functional Concept]
Processing 00000000.tx.351: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.352: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.353: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.354: USA, 100, 40784083.[Abstract/Free FullText] Goldberg, M.S., Fleming, S.M., Palacino, J.J., Cepeda, C., Lam, H.A., Bhatnagar, A., Meloni, E.G., Wu, N., Ackerson, L.C., Klapstein, G.J. et al. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "100,"

Phrase: "40784083."

Phrase: "[Abstract/Free FullText"

Phrase: "] Goldberg,"

Phrase: "M.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Fleming,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331812:Fleming [Health Care Related Organization]

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Palacino,"

Phrase: "J.J.,"

Phrase: "Cepeda,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lam,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "A.,"

Phrase: "Bhatnagar,"

Phrase: "A.,"

Phrase: "Meloni,"

Phrase: "E.G."

Phrase: ","

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ackerson,"

Phrase: "L.C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Klapstein,"

Phrase: "G.J. et al."
Processing 00000000.tx.355: (2003) Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin-deficient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "nigrostriatal deficits"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "but"

Phrase: "not loss of dopaminergic neurons."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   926   C3550005:Loss of dopaminergic neurons [Finding]
   844   C0598940:Loss of neurons [Finding]
           neuron loss
   760   C1517945:Loss [Quantitative Concept]
   756 E C1850496:Neuronal loss [Finding]
Processing 00000000.tx.356: J. 

Phrase: "J."
Processing 00000000.tx.357: Biol. 

Phrase: "Biol."
Processing 00000000.tx.358: Chem., 278, 4362843635.[Abstract/Free FullText] Itier, J.M., Ibanez, P., Mena, M.A., Abbas, N., Cohen-Salmon, C., Bohme, G.A., Laville, M., Pratt, J., Corti, O., Pradier, L. et al. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "4362843635."

Phrase: "[Abstract/Free FullText"

Phrase: "] Itier,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Ibanez,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Mena,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1425409:MENA [Gene or Genome]
  1000   C2348366:MENA [Gene or Genome]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Abbas,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cohen-Salmon,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036110:Salmon [Fish]
   861   C0327949:salmon [Fish]
   861   C0459210:Salmon [Food]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Bohme,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A.,"

Phrase: "Laville,"

Phrase: "M."

Phrase: ","

Phrase: "Pratt,"

Phrase: "J.,"

Phrase: "Corti,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Pradier,"

Phrase: "L. et al."
Processing 00000000.tx.359: (2003) Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin gene inactivation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0598496:Gene Inactivation [Genetic Function]
   827   C0544461:Inactivation [Cell or Molecular Dysfunction]
   734   C1418270:parkin gene [Gene or Genome]
   734   C2983548:Parkin Gene [Gene or Genome]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "behaviour"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0004927:Behavior [Individual Behavior]
  1000   C2707008:Behavior [Clinical Attribute]
   928 E C2986890:Behavioral [Idea or Concept]

Phrase: "and"

Phrase: "dopamine neurotransmission in the mouse."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027793:Neurotransmission [Cell Function]
Processing 00000000.tx.360: Hum. 

Phrase: "Hum."
Processing 00000000.tx.361: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.362: Genet., 12, 22772291.[Abstract/Free FullText] Ebersole, T.A., Chen, Q., Justice, M.J. and Artzt, K. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "22772291."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ebersole,"

Phrase: "T.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0193959:t a [Therapeutic or Preventive Procedure]
   861   C2603360:T' [Clinical Attribute]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Q.,"

Phrase: "Justice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022437:Justice [Qualitative Concept]

Phrase: "M."

Phrase: "J."

Phrase: "and"

Phrase: "Artzt,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.363: (1996) The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins. 

Phrase: "(1996"

Phrase: ")"

Phrase: "The quaking gene product"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017337:Gene [Gene or Genome]
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "necessary in embryogenesis"

Phrase: "and"

Phrase: "myelination"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0596991:myelination [Cell Function]
   928 E C0026973:Myelinated [Cell Component]

Phrase: "combines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336789:Combine [Manufactured Object]

Phrase: "features of RNA binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C1521970:Feature [Qualitative Concept]
   737   C1706388:Feature [Conceptual Entity]
   737   C2346469:Feature [Qualitative Concept]
   737   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "signal transduction proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0037083:Signal Transduction [Cell Function]
Processing 00000000.tx.364: Nat. 

Phrase: "Nat."
Processing 00000000.tx.365: Genet., 12, 260265.[Medline] Cox, R.D., Hugill, A., Shedlovsky, A., Noveroske, J.K., Best, S., Justice, M.J., Lehrach, H. and Dove, W.F. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "260265."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cox,"

Phrase: "R.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hugill,"

Phrase: "A.,"

Phrase: "Shedlovsky,"

Phrase: "A.,"

Phrase: "Noveroske,"

Phrase: "J.K.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Best,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1522427:Best [Qualitative Concept]
   966 E C0205170:Well [Qualitative Concept]
   966 E C3146287:Well [Manufactured Object]

Phrase: "S."

Phrase: ","

Phrase: "Justice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022437:Justice [Qualitative Concept]

Phrase: "M."

Phrase: "J.,"

Phrase: "Lehrach,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Dove,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325912:Dove [Bird]

Phrase: "W.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.366: (1999) Contrasting effects of ENU induced embryonic lethal mutations of the quaking gene. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Contrasting effects of ENU"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "embryonic lethal mutations of the quaking gene."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   797   C1516823:Embryonic Lethal Mutation [Cell or Molecular Dysfunction]
   774   C0017354:Lethal gene [Gene or Genome]
   774   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   748   C3151529:Lethal [Finding]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.367: Genomics, 57, 333341.[CrossRef][Medline] Lockhart, P.J., O'Farrell, C.A. and Farrer, M. 

Phrase: "Genomics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "57,"

Phrase: "333341."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lockhart,"

Phrase: "P.J.,"

Phrase: "O'Farrell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "C."

Phrase: "A."

Phrase: "and"

Phrase: "Farrer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.368: (2003) It's a double knock-out! 

Phrase: "(2003"

Phrase: ")"

Phrase: "It's a double knock-out!"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0560617:knock out [Injury or Poisoning]
   901   C1522225:Knock-out [Experimental Model of Disease]
   827   C0439787:Out [Spatial Concept]
   827   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.369: The quaking mouse is a spontaneous deletion of parkin and parkin co-regulated gene (PACRG). 

Phrase: "The quaking mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "is"

Phrase: "a spontaneous deletion of parkin and parkin co-regulated gene (PACRG)."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   757   C0017260:Gene Deletion [Genetic Function]
   757   C0079429:A Gene [Gene or Genome]
   757   C1418270:parkin gene [Gene or Genome]
           PARKIN
   757   C1442161:Gene Deletion [Cell or Molecular Dysfunction]
           Deletion
   757   C2983548:Parkin Gene [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]
   739   C0205359:Spontaneous [Functional Concept]
   739   C0851285:Regulated [Governmental or Regulatory Activity]
   739   C1511760:Deletion [Genetic Function]
   739   C1880274:Deletion [Activity]
   739   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.370: Mov. 

Phrase: "Mov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825516:MOV [Quantitative Concept]
Processing 00000000.tx.371: Disord., 19, 101104. 

Phrase: "Disord.,"

Phrase: "19,"

Phrase: "101104."
Processing 00000000.tx.372: Munoz, E., Tolosa, E., Pastor, P., Marti, M.J., Valldeoriola, F., Campdelacreu, J. and Oliva, R. 

Phrase: "Munoz,"

Phrase: "E.,"

Phrase: "Tolosa,"

Phrase: "E.,"

Phrase: "Pastor,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0684012:pastor [Professional or Occupational Group]
   928 E C1555897:Pastoral [Intellectual Product]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Marti,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Valldeoriola,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Campdelacreu,"

Phrase: "J."

Phrase: "and"

Phrase: "Oliva,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0228539:oliva [Body Part, Organ, or Organ Component]
  1000   C0228540:Oliva [Body Part, Organ, or Organ Component]
  1000   C0262254:oliva [Body Part, Organ, or Organ Component]
  1000   C1020282:Oliva [Eukaryote]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.373: (2002) Relative high frequency of the c.255delA parkin gene mutation in Spanish patients with autosomal recessive parkinsonism. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Relative high frequency of the c.255delA parkin gene mutation"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0205212:High frequency [Temporal Concept]
   757   C0017270:Gene Frequency [Quantitative Concept]
   757   C3178846:Mutation Frequency [Qualitative Concept]
   739   C0205250:High [Qualitative Concept]
   739   C0376249:frequency [Quantitative Concept]
   739   C0439603:Frequency [Temporal Concept]
   739   C0871396:Frequency [Quantitative Concept]
   739   C1299351:High [Qualitative Concept]
   739   C1561548:Frequency [Qualitative Concept]
   739   C1705502:Frequency [Quantitative Concept]
   739   C2700149:HIGH [Intellectual Product]

Phrase: "in Spanish patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with autosomal recessive parkinsonism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   827   C0242422:Parkinsonism [Disease or Syndrome]
   734   C0441748:Autosomal recessive [Intellectual Product]
Processing 00000000.tx.374: J. 

Phrase: "J."
Processing 00000000.tx.375: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.376: Neurosurg. 

Phrase: "Neurosurg."
Processing 00000000.tx.377: Psychiatry, 73, 582584.[Abstract/Free FullText] Maruyama, M., Ikeuchi, T., Saito, M., Ishikawa, A., Yuasa, T., Tanaka, H., Hayashi, S., Wakabayashi, K., Takahashi, H. and Tsuji, S. 

Phrase: "Psychiatry,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "73,"

Phrase: "582584."

Phrase: "[Abstract/Free FullText"

Phrase: "] Maruyama,"

Phrase: "M."

Phrase: ","

Phrase: "Ikeuchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Saito,"

Phrase: "M."

Phrase: ","

Phrase: "Ishikawa,"

Phrase: "A.,"

Phrase: "Yuasa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tanaka,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hayashi,"

Phrase: "S."

Phrase: ","

Phrase: "Wakabayashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Tsuji,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.378: (2000) Novel mutations, pseudo-dominant inheritance, and possible familial affects in patients with autosomal recessive juvenile parkinsonism. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Novel mutations,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C2985438:Novel Mutation [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "pseudo-dominant inheritance,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0678942:dominant inheritance [Genetic Function]
   827   C0242538:Inheritance [Quantitative Concept]
   827   C0728826:Inheritance [Functional Concept]

Phrase: "and"

Phrase: "possible familial"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:familial [Family Group]
   861   C0241888:Familial [Functional Concept]
   789 E C1704727:Family [Conceptual Entity]

Phrase: "affects in patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0522476:affect patients [Qualitative Concept]
   790   C0001721:Affect [Mental Process]
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "with autosomal recessive juvenile parkinsonism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.379: Ann. 

Phrase: "Ann."
Processing 00000000.tx.380: Neurol., 48, 245250.[CrossRef][Medline] Abbas, N., Lcking, C.B., Ricard, S., Drr, A., Bonifati, V., DeMichele, G., Bouley, S., Vaughan, J.R., Gasser, T., Marconi, R. et al. 

Phrase: "Neurol.,"

Phrase: "48,"

Phrase: "245250."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Abbas,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Lcking,"

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Ricard,"

Phrase: "S."

Phrase: ","

Phrase: "Drr,"

Phrase: "A.,"

Phrase: "Bonifati,"

Phrase: "V.,"

Phrase: "DeMichele,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bouley,"

Phrase: "S."

Phrase: ","

Phrase: "Vaughan,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Gasser,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Marconi,"

Phrase: "R. et al."
Processing 00000000.tx.381: (1999) A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. 

Phrase: "(1999"

Phrase: ")"

Phrase: "A wide variety of mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "in the parkin gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "are"

Phrase: "responsible for autosomal recessive parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "in Europe."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015176:Europe [Geographic Area]
Processing 00000000.tx.382: Hum. 

Phrase: "Hum."
Processing 00000000.tx.383: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.384: Genet., 8, 567574.[Abstract/Free FullText] Kann, M., Jacobs, H., Mohrmann, K., Schumacher, K., Hedrich, K., Garrels, J., Wiegers, K., Schwinger, E., Pramstaller, P.P., Breakefield, X.O. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "567574."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kann,"

Phrase: "M."

Phrase: ","

Phrase: "Jacobs,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mohrmann,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Schumacher,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hedrich,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Garrels,"

Phrase: "J.,"

Phrase: "Wiegers,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Schwinger,"

Phrase: "E.,"

Phrase: "Pramstaller,"

Phrase: "P.P.,"

Phrase: "Breakefield,"

Phrase: "X.O. et al."
Processing 00000000.tx.385: (2002) Role of parkin mutations in 111 community-based patients with early-onser parkinsonism. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Role of parkin mutations in 111 community-based patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "with early-onser parkinsonism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.386: Ann. 

Phrase: "Ann."
Processing 00000000.tx.387: Neurol., 51, 621625.[CrossRef][Medline] Xu, Y., Liu, Z., Wang, Y., Tao, E., Chen, G. and Chen, B. 

Phrase: "Neurol.,"

Phrase: "51,"

Phrase: "621625."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Xu,"

Phrase: "Y.,"

Phrase: "Liu,"

Phrase: "Z.,"

Phrase: "Wang,"

Phrase: "Y.,"

Phrase: "Tao,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   944   C0041165:Troleandomycin [Antibiotic,Organic Chemical]
   916 E C0040021:taos [Disease or Syndrome]
   916 E C1551534:Taos [Population Group]

Phrase: "E.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.388: (2002) A new point mutation on exon 2 of parkin gene in Parkinson's disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "A new point mutation on exon 2 of parkin gene"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   757   C0596611:Gene Mutation [Genetic Function]
   757   C2924612:A point [Body Location or Region]
   757   C2985439:new mutation [Cell or Molecular Dysfunction]
   739   C0026882:Mutation [Genetic Function]
   739   C1552961:Point [Quantitative Concept]
   739   C1705285:Mutation [Cell or Molecular Dysfunction]
   739   C2347617:point [Quantitative Concept]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.389: Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 19, 409411.[Medline] Foroud, T., Uniacke, S.K., Liu, L., Pankratz, N., Rudolph, A., Halter, C., Shults, C., Marder, K., Conneally, P.M. and Nichols, W.C. 

Phrase: "Zhonghua Yi Xue Yi Chuan Xue Za Zhi,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   878   C1089993:yi zhi [Plant]
   878   C1869287:yi-zhi [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "19,"

Phrase: "409411."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Foroud,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Uniacke,"

Phrase: "S."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Liu,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Pankratz,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Rudolph,"

Phrase: "A.,"

Phrase: "Halter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441229:Halter [Medical Device]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Shults,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Marder,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Conneally,"

Phrase: "P.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Nichols,"

Phrase: "W.C."
Processing 00000000.tx.390: (2003) Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Heterozygosity for a mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019425:Heterozygosity [Organism Attribute]

Phrase: "in the parkin gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "leads to later onset Parkinson disease."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   871   C3160718:PARKINSON DISEASE, LATE-ONSET [Disease or Syndrome]
   803   C0814122:late disease onset [Finding]
   790   C0030567:Parkinson Disease [Disease or Syndrome]
   790   C1521736:Parkinson's Disease [Functional Concept]
   790   C2681933:PARKINSON DISEASE [Gene or Genome]
   783   C0277793:disease onset [Temporal Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0181586:leads [Medical Device]
   753   C0332162:Onset [Qualitative Concept]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]
   719   C0205087:Late [Temporal Concept]
Processing 00000000.tx.391: Neurology, 60, 796801.[Abstract/Free FullText] Hattori, N., Matsumine, H., Asakawa, S., Kitada, T., Yoshino, H., Elibol, B., Brookes, A.J., Yamamura, Y., Kobayashi, T., Wang, M. et al. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "60,"

Phrase: "796801."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Matsumine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Kitada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yoshino,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Elibol,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Brookes,"

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "Yamamura,"

Phrase: "Y.,"

Phrase: "Kobayashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Wang,"

Phrase: "M. et al."
Processing 00000000.tx.392: (1998) Point mutations (Thr240Arg and Gln311Stop) [correction of Thr240Arg and Ala311Stop] in the Parkin gene. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Point mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(Thr240Arg"

Phrase: "and"

Phrase: "Gln311Stop"

Phrase: ")"

Phrase: "[correction of Thr240Arg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1705565:CORRECTION [Intellectual Product]
   790   C1947976:Correction [Functional Concept]

Phrase: "and"

Phrase: "Ala311Stop"

Phrase: "]"

Phrase: "in the Parkin gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.393: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.394: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.395: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.396: Commun., 251, 666.[CrossRef] Pineda-Trujillo, N., Carvajal-Carmona, L.G., Buritica, O., Moreno, S., Uribe, C., Pineda, D., Toro, M., Garcia, F., Arias, W., Bedoya, G. et al. 

Phrase: "Commun.,"

Phrase: "251,"

Phrase: "666."

Phrase: "[CrossRef"

Phrase: "] Pineda-Trujillo,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Carvajal-Carmona,"

Phrase: "L.G.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439294:l g [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "Buritica,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Moreno,"

Phrase: "S."

Phrase: ","

Phrase: "Uribe,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pineda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1678385:Pineda [Plant]

Phrase: "D."

Phrase: ","

Phrase: "Toro,"

Phrase: "M."

Phrase: ","

Phrase: "Garcia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442999:Garcia [Intellectual Product]
  1000   C1621797:Garcia [Plant]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Arias,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006301:Aria [Plant]

Phrase: "W.,"

Phrase: "Bedoya,"

Phrase: "G. et al."
Processing 00000000.tx.397: (2001) A novel Cys212Tyr founder mutation in parkin and allelic heterogeneity of juvenile Parkinsonism in a population from North West Colombia. 

Phrase: "(2001"

Phrase: ")"

Phrase: "A novel Cys212Tyr founder mutation in parkin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C2985435:Founder Mutation [Cell or Molecular Dysfunction]
   774   C2985438:Novel Mutation [Cell or Molecular Dysfunction]
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "allelic heterogeneity of juvenile Parkinsonism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C2986469:Allelic Heterogeneity [Qualitative Concept]
   760   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "in a population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "from North West Colombia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0009367:Colombia [Geographic Area]
Processing 00000000.tx.398: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.399: Lett., 298, 8790.[CrossRef][Medline] Hedrich, K., Marder, K., Harris, J., Kann, M., Lynch, T., Meija-Santana, H., Pramstaller, P.P., Schwinger, E., Bressman, S.B., Fahn, S. et al. 

Phrase: "Lett.,"

Phrase: "298,"

Phrase: "8790."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hedrich,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Marder,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Harris,"

Phrase: "J.,"

Phrase: "Kann,"

Phrase: "M."

Phrase: ","

Phrase: "Lynch,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Meija-Santana,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Pramstaller,"

Phrase: "P.P.,"

Phrase: "Schwinger,"

Phrase: "E.,"

Phrase: "Bressman,"

Phrase: "S."

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Fahn,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1823105:FAHN [Gene or Genome]

Phrase: "S. et al."
Processing 00000000.tx.400: (2002) Evaluation of 50 Probands with Early-Onset Parkinson's Disease for Parkin Mutations. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Evaluation of 50 Probands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0220825:Evaluation [Functional Concept]
   770   C1261322:Evaluation [Health Care Activity]

Phrase: "with Early-Onset Parkinson's Disease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   902   C0679245:early disease [Temporal Concept]
   861   C0030567:Parkinson Disease [Disease or Syndrome]
   861   C1521736:Parkinson's Disease [Functional Concept]
   861   C2681933:PARKINSON DISEASE [Gene or Genome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
   712   C1021144:Parkinsonia [Plant]

Phrase: "for Parkin Mutations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.401: Neurology, 58, 12391246.[Abstract/Free FullText] Oliveira, S.A., Scott, W.K., Martin, E.R., Nance, M.A., Watts, R.L., Hubble, J.P., Koller, W.C., Pahwa, R., Stern, M.B., Hiner, B.C. et al. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "58,"

Phrase: "12391246."

Phrase: "[Abstract/Free FullText"

Phrase: "] Oliveira,"

Phrase: "S.A.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Scott,"

Phrase: "W.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Martin,"

Phrase: "E.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Nance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330910:nance [Plant]

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Watts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439261:Watt [Quantitative Concept]

Phrase: "R.L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hubble,"

Phrase: "J.P.,"

Phrase: "Koller,"

Phrase: "W.C., Pahwa,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stern,"

Phrase: "M.B.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hiner,"

Phrase: "B.C. et al."
Processing 00000000.tx.402: (2003) Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "susceptibility alleles in late-onset Parkinson's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0002085:Alleles [Gene or Genome]
Processing 00000000.tx.403: Ann. 

Phrase: "Ann."
Processing 00000000.tx.404: Neurol., 53, 624629.[CrossRef][Medline] Klein, C., Schumacher, K., Jacobs, H., Hagenah, J., Kis, B., Garrels, J., Schwinger, E., Ozelius, L., Pramstaller, P., Vieregge, P. et al. 

Phrase: "Neurol.,"

Phrase: "53,"

Phrase: "624629."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Klein,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Schumacher,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Jacobs,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hagenah,"

Phrase: "J.,"

Phrase: "Kis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1540160:KIS [Gene or Genome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Garrels,"

Phrase: "J.,"

Phrase: "Schwinger,"

Phrase: "E.,"

Phrase: "Ozelius,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Pramstaller,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vieregge,"

Phrase: "P. et al."
Processing 00000000.tx.405: (2000) Association studies of Parkinson's disease and parkin polymorphisms [letter]. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "studies of Parkinson's disease"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "parkin polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "[letter"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1096774:Letter [Intellectual Product]
  1000   C2360551:Letter [Clinical Attribute]
   944 E C0079691:Levothyroxine Sodium [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C0282413:letters [Intellectual Product]
   916 E C0728762:Synthroid [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "]."
Processing 00000000.tx.406: Ann. 

Phrase: "Ann."
Processing 00000000.tx.407: Neurol., 48, 126127.[CrossRef] Wang, T., Liang, Z., Sun, S., Cao, X., Peng, H., Cao, F., Liu, H. and Tong, E.T. 

Phrase: "Neurol.,"

Phrase: "48,"

Phrase: "126127."

Phrase: "[CrossRef"

Phrase: "] Wang,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Liang,"

Phrase: "Z.,"

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "S."

Phrase: ","

Phrase: "Cao,"

Phrase: "X.,"

Phrase: "Peng,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Cao,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Liu,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Tong,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0183964:Tong [Medical Device]

Phrase: "E.T."
Processing 00000000.tx.408: (2003) Point mutation in the parkin gene on patients with Parkinson's disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Point mutation in the parkin gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   783   C0596611:Gene Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C1552961:Point [Quantitative Concept]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]
   753   C2347617:point [Quantitative Concept]

Phrase: "on patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.409: J. 

Phrase: "J."
Processing 00000000.tx.410: Huazhong Univ. 

Phrase: "Huazhong Univ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:UNIV [Manufactured Object,Organization]
Processing 00000000.tx.411: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.412: Technolog. 

Phrase: "Technolog."
Processing 00000000.tx.413: Med. 

Phrase: "Med."
Processing 00000000.tx.414: Sci., 23, 145147.[Medline] Munoz, E., Pastor, P., Marti, M.J., Oliva, R. and Tolosa, E. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "145147."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Munoz,"

Phrase: "E.,"

Phrase: "Pastor,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0684012:pastor [Professional or Occupational Group]
   928 E C1555897:Pastoral [Intellectual Product]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Marti,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Oliva,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0228539:oliva [Body Part, Organ, or Organ Component]
  1000   C0228540:Oliva [Body Part, Organ, or Organ Component]
  1000   C0262254:oliva [Body Part, Organ, or Organ Component]
  1000   C1020282:Oliva [Eukaryote]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Tolosa,"

Phrase: "E."
Processing 00000000.tx.415: (2000) A new mutation in the parkin gene in a patient with atypical autosomal recessive juvenile parkinsonism. 

Phrase: "(2000"

Phrase: ")"

Phrase: "A new mutation in the parkin gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C2985439:new mutation [Cell or Molecular Dysfunction]
   774   C0596611:Gene Mutation [Genetic Function]
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in a patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "with atypical autosomal recessive juvenile parkinsonism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   937   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   888   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   840   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   804   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.416: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.417: Lett., 289, 6668.[CrossRef][Medline] Alvarez, V., Guisasola, L., Moreira, V., Lahoz, C. and Coto, E. 

Phrase: "Lett.,"

Phrase: "289,"

Phrase: "6668."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Alvarez,"

Phrase: "V.,"

Phrase: "Guisasola,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Moreira,"

Phrase: "V.,"

Phrase: "Lahoz,"

Phrase: "C."

Phrase: "and"

Phrase: "Coto,"

Phrase: "E."
Processing 00000000.tx.418: (2001) Early-onset Parkinson's disease associated with a new parkin mutation in a Spanish family. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Early-onset Parkinson's disease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   902   C0679245:early disease [Temporal Concept]
   861   C0030567:Parkinson Disease [Disease or Syndrome]
   861   C1521736:Parkinson's Disease [Functional Concept]
   861   C2681933:PARKINSON DISEASE [Gene or Genome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
   712   C1021144:Parkinsonia [Plant]

Phrase: "associated with a new parkin mutation"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C2985439:new mutation [Cell or Molecular Dysfunction]
   753   C0026882:Mutation [Genetic Function]
   753   C0205314:New [Temporal Concept]
   753   C1418270:PARKIN [Gene or Genome]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in a Spanish family."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.419: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.420: Lett., 313, 108110.[CrossRef][Medline] Nichols, W.C., Pankratz, N., Uniacke, S.K., Pauciulo, M.W., Halter, C., Rudolph, A., Conneally, P.M. and Foroud, T. 

Phrase: "Lett.,"

Phrase: "313,"

Phrase: "108110."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nichols,"

Phrase: "W.C., Pankratz,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Uniacke,"

Phrase: "S."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Pauciulo,"

Phrase: "M."

Phrase: "W., Halter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441229:Halter [Medical Device]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Rudolph,"

Phrase: "A.,"

Phrase: "Conneally,"

Phrase: "P.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Foroud,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.421: (2002) Linkage stratification and mutation analysis at the Parkin locus identifies mutation positives Parkinson's disease families. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Linkage stratification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514983:Stratification [Research Activity]

Phrase: "and"

Phrase: "mutation analysis at the Parkin locus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0796357:mutation analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "identifies"

Phrase: "mutation positives Parkinson's disease families."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0344339:disease family [Finding]
   804   C0015576:Families [Family Group]
   804   C1704727:Family [Conceptual Entity]
   721 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.422: J. 

Phrase: "J."
Processing 00000000.tx.423: Med. 

Phrase: "Med."
Processing 00000000.tx.424: Genet., 39, 489492.[Free FullText] Chen, R., Gosavi, N.S., J.W., L. and Chan, P. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "39,"

Phrase: "489492."

Phrase: "[Free FullText"

Phrase: "] Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gosavi,"

Phrase: "N.S.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "J.W., L."

Phrase: "and"

Phrase: "Chan,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.425: (2003) Parkin mutations are rare in patients with young-onset parkinsonism in a US population. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "rare in patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0521114:Rare [Temporal Concept]
   790   C0522498:Rare [Qualitative Concept]
   790   C1514917:RARE [Gene or Genome]

Phrase: "with young-onset parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "in a"

Phrase: "US population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]
Processing 00000000.tx.426: Parkinsonism Relat. 

Phrase: "Parkinsonism Relat."
Processing 00000000.tx.427: Disord., 9, 309312.[Medline] Hu, C.J., Sung, S.M., Liu, H.C., Lee, C.C., Tsai, C.H. and Chang, J.G. 

Phrase: "Disord.,"

Phrase: "9,"

Phrase: "309312."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hu,"

Phrase: "C.J.,"

Phrase: "Sung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0037173:SING [Geographic Area]
   966   C0234857:sing [Individual Behavior]

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Liu,"

Phrase: "H.C.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Lee,"

Phrase: "C.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Tsai,"

Phrase: "C.H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Chang,"

Phrase: "J.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.428: (2000) Polymorphisms of the parkin gene in sporadic Parkinson's disease among Chinese in Taiwan. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Polymorphisms of the parkin gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0678951:gene polymorphisms [Genetic Function]
   760   C0032529:polymorphisms [Genetic Function]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in sporadic Parkinson's disease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C0030567:Parkinson Disease [Disease or Syndrome]
   901   C1521736:Parkinson's Disease [Functional Concept]
   901   C2681933:PARKINSON DISEASE [Gene or Genome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205422:Sporadic [Temporal Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   727   C1021144:Parkinsonia [Plant]

Phrase: "among Chinese"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008120:chinese [Language]
  1000   C0152035:Chinese [Population Group]

Phrase: "in Taiwan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039260:Taiwan [Geographic Area]
Processing 00000000.tx.429: Eur. 

Phrase: "Eur."
Processing 00000000.tx.430: Neurol., 44, 9093.[CrossRef][Medline]

Phrase: "Neurol.,"

Phrase: "44,"

Phrase: "9093."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

